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The association between dental procedures, oral bacteria and infective endocarditis (IE) 
is contentious, particularly following changes in UK guidance on antibiotic prophylaxis in 
recent years. Although IE in children is rare, the disease carries a high risk of mortality 
and morbidity, and several cases of orthodontic-induced IE have been reported. 
Evidence suggests that orthodontic separator placement induces bacteraemia with oral 
streptococci, potential causative agents in IE. However, a detailed understanding of how 
such bacteria survive in blood is currently lacking. 
This study aimed to determine the blood survival mechanisms of oral streptococci 
commonly implicated in orthodontic separator placement. In particular, the role of 
bacterial surface determinants and evasion of complement-mediated killing in 
promoting streptococcal survival in blood were investigated. 
This work identified that bacterial blood survival rates are species- and strain-
dependent, with a general correlation between IE-associated species and persistence 
in blood. IE pathogen Streptococcus gordonii surface proteins PadA and Hsa both 
bound Factor H and vitronectin, indicating two mechanisms by which S. gordonii may 
evade the host immune system. 
Better understanding of mechanisms for streptococcal survival in the bloodstream, 
such as those identified in this project, could identify novel targets for the prevention 
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1. Literature review 
1.1. The role of oral bacteria in health and systemic disease 
1.1.1. Historical perspective 
The mouth is often described as a ‘window’ into the health of the body, but the link 
between oral health and systemic health is not new. The importance of good oral 
hygiene was recognised as early as the Ancient Greek civilisation (O'Reilly and Claffey, 
2000), and the eradication of mouth infections in patients with rheumatic joint 
problems was reported to cure symptoms by Hippocrates (Mayo, 1922). Antonie van 
Leeuwenhoek, a 17th century Dutch scientist, was the first to link a lack of oral hygiene 
to an increase in microorganisms, which he named “animalcules” in dental plaque. He 
was also the first scientist to use a microscope and is often referred to as the ‘Father of 
Oral Microbiology’.  
William Hunter, a British surgeon, published a report in 1900 emphasising the role of 
oral sepsis as a cause of disease (Hunter, 1900). Removal of teeth was common in the 
first half of the 20th century due to the popularisation of this focal infection theory, 
where localised infections were thought to be responsible for the initiation of 
inflammatory diseases. Conservative treatment became more popular in the second 
half of the 20th century, enabling patients to retain their dentition for longer. A seminal 
paper was published in 1989, reporting that oral health was significantly worse in 
patients with myocardial infarction, after adjusting for risk factors (Mattila et al., 1989). 
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The turn of the 21st century saw an increased recognition that the oral cavity can act as 
a source of pathogenic bacteria and their products. 
1.1.2. The role of oral bacteria in health 
The oral cavity is a highly specialised environment, comprising several different soft 
and hard tissues, operating under constantly changing physical and chemical 
conditions. As a consequence, there are a number of different habitats for 
microorganisms. An estimated 700 bacterial species can inhabit the oral cavity 
(Dewhirst et al., 2010), with between 100 and 200 species typically found in any one 
individual. However, problems with cultivation mean that so far only around half of the 
potential species have been named or isolated. By living in communities, known as 
biofilms, bacteria are more likely to survive in the relatively hostile conditions of the 
oral environment. 
A biofilm is a collection of microorganisms found typically at the interface between two 
phases, enclosed within an extracellular matrix (Flemming and Wingender, 2010). 
Dental plaque is a widely studied example of a biofilm and comprises microorganisms 
enveloped within a matrix consisting of salivary components, bacterially-derived 
polymers and food particles. Salivary pellicle is the film that coats tooth surfaces and 
soft tissues, and this is a critical substratum for colonising oral bacteria, such as 
streptococci. The stages of oral biofilm formation are summarised in Figure 1.1. Briefly, 
bacteria in a planktonic state interact with newly-formed salivary pellicle on tooth 
surfaces. These primary coloniser bacterial cells adhere and aggregate to form a 
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‘linking film’, which then serves as the foundation for biofilm development. Inter- and 
intraspecies binding between bacterial cells (coadhesion) leads to accretion of the 
biofilm, including the incorporation of Gram-negative and anaerobic microorganisms, 
with the potential for pathogenic effects. The bacteria now function as a community in 






Figure 1.1 Stages in oral biofilm formation 
a) Attachment of bacterial cells via non-specific forces  
b) Higher affinity adhesion via specific receptors 
c) Linking film formation 
d) Planktonic cell recruitment 
e) Maturation of the biofilm comprising multiple bacterial species 
 
Microbial communities, known as microbiomes, are found in and on many parts of the 
body, and the microbial component of the human holobiont is substantial, equalling 
the number of human cells (Sender, Fuchs and Milo, 2016). There are many positive 
effects of host-microbiome symbiosis, including anti-inflammatory properties, anti-
oxidant activity, maintenance of a healthy digestive tract and resistance to colonisation 
by pathogens (Kilian et al., 2016). The role of the oral microbiome in health and disease 
has been studied widely in recent years, and when resident species in the oral cavity 
a b c d e 
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are in equilibrium with each other and with the host, a symbiotic or health state exists. 
The role of early colonisers is important here, with formation of a stable microbial 
community that inhibits colonisation by incoming pathogens. This concept is known as 
colonisation resistance, and was first described in the 1950s with regards to antibiotic-
mediated disruption of intestinal tract microbial communities (Bohnhoff, Drake and 
Miller, 1954). A complex balance of microbe-host and microbe-microbe interactions is 
required to mediate protection against invading pathogens throughout life in a healthy 
host (Lawley and Walker, 2013). Other changes in the local environment that can 
disturb the diversity and relative proportions of species within a community, leading to 
a so-called dysbiotic microbiome, include changes in oral hygiene, diet, smoking and 
diseases such as diabetes (Kilian et al., 2016).  
A recent systematic review found the use of oral probiotics may promote maintenance 
of good oral health by reducing the microbial load of oral pathogens (Seminario-Amez 
et al., 2017). More personalised treatment has also been proposed for the clinical 
management of diseases such as caries and periodontal disease, through the use of 
oral microbiome transplants (Allaker and Stephen, 2017). 
1.1.3. The role of oral bacteria in systemic disease 
Many associations between oral and systemic diseases have been found. These include 
heart disease (Mustapha et al., 2007), ventilator-associated pneumonia (Heo et al., 
2008), adverse pregnancy outcome (Han, 2011), diabetes mellitus (Molina et al., 2016), 
rheumatoid arthritis (Kaur et al., 2014), inflammatory bowel disease (Strauss et al., 
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2011), colorectal cancer (Castellarin et al., 2012) and liver disease (Han, Sun and Yang, 
2016). Many of these diseases share risk factors such as age, male gender, smoking, 
alcohol, hypertension, social isolation and stress (Beck et al., 1996). However, while 
associations clearly exist, causation between oral bacteria and systemic disease has 
often been more difficult to determine. Three mechanisms for the link between oral 
microbes and systemic diseases have been suggested (Thoden van Velzen, Abraham-
Inpijn and Moorer, 1984). These are described below and in Figure 1.2. 
1) Bacteraemia and extra-oral site colonisation 
The entry of oral bacteria into the blood may allow colonisation at sites away 
from the oral cavity. Normal physiological activities, such as chewing and tooth-
brushing, can result in bacteraemia. This is in fact an old concept as described 
by Elliott in 1939: 
“bacteria may also gain admission to the blood-stream in such cases 
irrespective of operative procedures and probably as the result, in many 
instances, of minor degrees of gum injury such as is produced by biting 
on a loose tooth” (Elliott, 1939) 
It is thought that cumulative levels of bacteraemia are higher during day-to-day 
activities, including flossing or chewing, than after a single tooth extraction 
(Que and Moreillon, 2011). Both cardiovascular and non-cardiovascular sites 
are often found to be colonised by oral microorganisms (Han and Wang, 2013). 
These microorganisms have adapted to survive at such extra-oral sites, escaping 
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host surveillance and developing mechanisms to persist at these sites (Han and 
Wang, 2013). 
2) Systemic injury from bacterial toxins 
Toxin production by oral bacteria (e.g. endotoxins) can directly damage the 
host. Lipopolysaccharide (LPS), an endotoxin found in the outer membrane of 
Gram-negative bacteria such as Aggregatibacter actinomycetemcomitans and 
Porphyromonas gingivalis is associated with cerebral infarction, adverse 
pregnancy outcome and idiopathic trigeminal neuralgia (Li et al., 2000b), as well 
as fever, toxic shock and apoptosis (Lamont, Hajishengallis and Jenkinson, 
2014). 
3) Systemic inflammation as a result of immunological response to oral microbes 
The deposition of immune complexes, which form when soluble antigens from 
oral bacteria react with circulating antibodies, can lead to chronic or acute 
inflammation. Levels of inflammatory mediators, such as prostaglandin E2, 
interleukin-1β and tumour necrosis factor α, become raised. Several conditions 
have been associated with systemic inflammation caused by oral 
microorganisms, including inflammatory bowel disease (Van Dyke et al., 1986), 




Figure 1.2 Mechanisms linking oral bacteria and systemic disease (adapted from 
Haworth et al., 2017b).  
VAP = ventilator-associated pneumonia; IBD = inflammatory bowel disease; APO = 
adverse pregnancy outcome; RA = rheumatoid arthritis 
  
22 
1.2. Effects of orthodontic treatment on the oral microbiome 
It has been recognised for many decades that wearing orthodontic appliances 
increases the likelihood of dental plaque retention. In Bloom and Brown’s study of 
1964, there was an increase in several microbial populations following the placement 
of orthodontic appliances, with the microbial increase proportional to the number of 
orthodontic bands in the mouth. Research regarding the effects of wearing fixed 
orthodontic appliances has shown that the bracket base is a critical site for plaque 
accumulation, particularly where excess bonding composite is present 
(Sukontapatipark et al., 2001). The relative impact of bonds versus bands in fixed 
orthodontic appliances has also been the subject of investigation over the years. 
Ireland et al. (2014) showed that molar bonds are more likely to elicit changes towards 
a microbiota with raised disease potential, compared to molar bands. This is in contrast 
to evidence from Boyd and Baumrind (1992), where banded molars showed increased 
plaque accumulation compared to bonded molars. 
The formation of white spot lesions or decalcification around fixed orthodontic 
appliances is common, although the reported incidence varies widely from 50% 
(Gorelick, Geiger and Gwinnett, 1982) to 97% (Boersma et al., 2005). Decalcification 
often occurs early in treatment, with a sharp increase in the number of white spot 
lesions during the first 6 months of treatment and a slower rate of increase in the 
following months (Tufekci et al., 2011). As in any carious lesion, there is an ecological 
shift in the dental biofilm towards a bacterial population that is aciduric. Balenseifen 
and Madonia (1970) reported a rise in Lactobacillus content of plaque after 
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orthodontic band placement, with concurrent increases in Streptococcus salivarius and 
Streptococcus mitis. Orthodontic band placement changes the chemical composition in 
the oral cavity, with decreased pH, calcium ion and phosphate ion levels, favouring 
more acidogenic plaque (Chatterjee and Kleinberg, 1979). It is also likely that the 
materials from which fixed appliances are made alter the plaque composition. 
Cariogenic streptococci have been found to adhere more readily to plastic rather than 
monocrystalline brackets (Ahn, Lim and Lee, 2007). Streptococcus mutans is the classic 
microorganism associated with caries, but recent evidence has suggested that there 
may be a role for S. gordonii in enamel demineralisation around orthodontic appliances 
(Sadeq et al., 2015). 
There is conflicting evidence regarding the long-term effects of orthodontic treatment 
on the microbiota, particularly in relation to periodontal health. Periodontal 
pathogens, such as Selenomonas species and P. gingivalis, Tannerella forsythia and 
Eubacterium nodatum have been associated with fixed appliance treatment (Ireland et 
al., 2014; Koopman et al., 2015). A study by Van Gastel and Quirynen (2008) reported 
that microbial and clinical periodontal changes occurred in patients undergoing fixed 
appliance treatment, with the changes occurring more quickly at bonded sites 
compared to banded sites. The picture is further complicated by the differences that 
occur between adolescents and adults during treatment. Adolescents with fixed 
appliances show more gingival inflammation and plaque accumulation than adults 
(Boyd and Baumrind, 1992). Others have reported that there is no increased risk for 
high levels of periodontal pathogens from fixed appliance therapy (Thornberg et al., 
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2009). Nevertheless, Soro et al. (2014) identified the candidate division TM7 
microorganism associated with orthodontic bonds. This microorganism is thought to 
have a preference for the subgingival mature plaque associated with periodontal 
disease (Brinig et al., 2003) and is now known to establish a long-term parasitic 
association with bacterial host Actinomyces odontolyticus (Bor et al., 2018). 
The oral microbial community shows remarkable resilience to the use of orthodontic 
appliances (Koopman et al., 2015), although there is evidence that even 1 year after 
orthodontic treatment is completed, restoration to pre-treatment microbiota fails to 
occur (Ireland et al., 2014). The long-term effects of orthodontic treatment on the oral 
microbiome are therefore not fully understood. 
1.3. Oral bacteria and heart disease 
Cardiovascular disease continues to be a major burden in the UK (Bhatnagar et al., 
2015), despite widespread use of anti-cholesterol treatment and promotion of healthy 
lifestyles. Microbial infection is thought to be a risk factor for cardiovascular disease, 
and bacteraemia incidence is rising. This may be due to increasing numbers of 
interventional procedures (Fitzgerald, Foster and Cox, 2006). Oral streptococci, 
commonly implicated in infective endocarditis (IE), can be isolated from blood culture 
following physiological activities and this may be as important to disease pathogenesis 
as dentistry-induced bacteraemia (Roberts, 1999). Others have calculated that 
cumulative levels of bacteraemia are higher during day-to-day activities, such as 
chewing or flossing, than after a single tooth extraction (Que and Moreillon, 2011). 
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Periodontal disease is thought to be associated with atherosclerosis, the result of 
artery wall thickening with a concurrent inflammatory component (Ross, 1999), and 
periodontal pathogens can be found in atherosclerotic plaques (Haraszthy et al., 2000). 
Increased serum antibody levels to oral anaerobes are found in some patients with 
acute myocardial infarction (MI) (Burazor and Vojdani, 2014). Stroke is the result of 
thrombotic ischaemia or haemorrhage, and evidence supports associations between 
oral infections and stroke (Syrjanen et al., 1989; Hashemipour et al., 2013).  
1.3.1. Infective endocarditis 
IE is characterised by the formation of infected vegetations on the endocardial surface 
of the heart, with the heart valve surfaces commonly implicated (Figure 1.3). These 
vegetations comprise bacteria, fibrin and platelets. The morbidity and mortality rates 
of IE are high, with between 15% and 20% of endocarditis patients dying during their 
initial hospital admission (Thornhill et al., 2016b). Mortality rates are high because the 
sequelae of IE, if treatment is not successful, include embolism, valve dysfunction with 
subsequent heart failure or uncontrolled infection (Cahill and Prendergast, 2016). In 
fact, it has been suggested that IE should be viewed as a form of systemic sepsis 
(Wallace et al., 2002). Sepsis occurs when there is a deregulated response to infection, 
leading to systemic inflammation (Shannon, 2015). 
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Figure 1.3 The heart with infected vegetations. 
The vegetations are shown and the valve sites highlighted. 
 
1.3.1.1. Epidemiology 
The incidence of IE has been reported as 1-5 per 100,000 in the American and 
European general populations per year (Tleyjeh et al., 2007). In the UK there are over 
2000 cases annually (Thornhill et al., 2016b), and evidence suggests that the incidence 
of IE has risen in recent years following the withdrawal of prescriptions for antibiotic 
prophylaxis prior to invasive dental procedures. This was in response to revised 




Left-sided native valve endocarditis is the most common form of IE and this tends to 
occur in patients with congenital heart defects or damaged heart surfaces from 
rheumatic fever. The most severe form of IE is left-sided prosthetic valve endocarditis. 
This can be categorised as early, often due to surgery-related microbes such as 
staphylococci, or late, occurring more than 12 months after surgery and often 
connected with oral streptococci or Gram-negative microorganisms. Risk groups that 
have emerged in recent years include haemodialysis patients, patients with valve 
sclerosis and IV-drug abusers (Fitzgerald, Foster and Cox, 2006). The latter are 
particularly prone to right-sided IE, with the causative agents often arising from the 
skin, such as staphylococci. A recent study by Rosenthal et al. (2016) reported that 
injection-drug users are at risk of recurrent IE, high rates of readmission and death 
rates in the region of 25%. Healthcare-associated endocarditis is the final category of IE 
and this can occur in both nosocomial and non-nosocomial settings.  
IE is a rare diagnosis in children. A district general hospital-based paediatrician is only 
likely to see 1-2 cases per year in the UK (Singh and Ganjoo, 2017). Despite this, 
paediatricians often have a high index of clinical suspicion regarding IE because of the 
associated high morbidity and mortality. Diagnosis is difficult because the classical 
signs of endocarditis are often absent in children. At risk children have historically been 
those who have suffered from rheumatic heart disease. Currently the main risk groups 
are children with congenital heart defects, intra-cardiac repairs and central venous 
catheters (Singh and Ganjoo, 2017). However, 10% of children have no identifiable risk 
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factors. Staphylococci are reported to account for 43% of IE cases in children, with 
streptococci accounting for 39% of cases (Grattan et al., 2015).  
1.3.1.2. Pathogenesis 
Three critical elements are required for IE pathogenesis (Sullam, Drake and Sande, 
1985). Firstly, the cardiac valve surface must be altered to allow bacterial adherence. 
For example, trauma can alter the endothelial surface, leading to platelet and fibrin 
deposition and surface disruption. Secondly, circulating bacteria adhere to the altered 
valve surface, with some bacteria adhering to the platelet-fibrin matrix on the surface 
more readily than others. Thirdly, the adherent bacteria must survive and resist host 
immune responses, such as the complement cascade, with propagation of the infected 
vegetation. Activation of the clotting cascade results in growth of a platelet-fibrin clot 
over the bacteria. The infected vegetation can then break away and seed at other 
susceptible sites (Sullam, Drake and Sande, 1985). 
The importance of bacteria-platelet interactions has emerged in recent years, as well 
as the complexities of the non-thrombotic roles of platelets. Bacteria can trigger 
platelet adhesion, aggregation, spreading and thrombus formation, and it is 
hypothesised that platelets can restrict the spread of infection and control the immune 
response through the release of contents from their intracellular granules. 
Alternatively, bacteria-platelet interactions could be regarded as a mechanism by 
which bacteria can protect themselves via a platelet coating from immune cell attack 
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or antibiotic penetration (Kerrigan, 2015). Streptococcal-platelet interactions will be 
described in more detail in section 1.5.3. 
1.3.1.3. Microbiology of endocarditis 
Together, enterococci, streptococci and Staphylococcus aureus are responsible for 
more than 80% of cases of IE (Fitzgerald, Foster and Cox, 2006).  
Enterococci, most frequently Enterococcus faecalis, cause 5-20% of cases of IE. The 
most frequent source of infection is the genitourinary tract, and both normal and 
previously damaged cardiac valves can be affected (Megran, 1992). E. faecalis has been 
shown to interact with platelets via platelet receptor FcγRIIa and host IgG (Rasmussen 
et al., 2010).  
Oral streptococci are responsible for 35-45% of cases of IE (Dayer et al., 2015). They 
are common causes of both native valve and late prosthetic valve endocarditis. Their 
role in IE will be covered in more detail below. 
S. aureus is a facultative anaerobe that can cause a range of diseases. IE in IV drug 
users, prosthetic valve IE and healthcare-related IE are particularly associated with S. 
aureus (Que and Moreillon, 2011). The increase in these risk groups has led to an 
increased incidence of staphylococcal endocarditis. Platelets are thought to interact 
with staphylococci via three main mechanisms: 1) through the release of toxins such as 
α-toxin; 2) as a result of cell-wall protein-mediated platelet activation; and 3) through 
platelet internalisation of S. aureus cells (Kerrigan and Cox, 2012). 
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Although rare, IE can be caused by fungal species and these are particularly important 
in cases of early prosthetic valve endocarditis (Que and Moreillon, 2011). Candidal 
endocarditis has a particularly high mortality rate and is increasingly becoming a 
healthcare-associated disease (Mohammadi, Mohammadi and Forrest, 2013). Candida 
species are known to cause platelet aggregation (Willcox et al., 1998). 
1.4. Oral streptococci  
Streptococci are Gram-positive bacteria that grow in pairs or chains. They are generally 
facultative anaerobes and more than 100 species have been recognised. Six taxonomic 
groupings have been described: pyogenic, salivarius, bovis, mutans, mitis and 
anginosus (Nobbs, Lamont and Jenkinson, 2009). Streptococci within the oral cavity are 
often also collectively referred to as viridans group streptococci (VGS). This is due to 
the alpha haemolysis that occurs when these streptococci are grown on blood agar, 
leading to a green colouration of the agar; “viridans” means “greening” in Latin. VGS 
are early colonisers of the oral cavity and play an important role in colonisation 
resistance. They are generally commensal microorganisms, but they can become 
pathogenic when they enter the bloodstream. They have many surface proteins 
capable of binding to oral surfaces and to endothelial tissue, platelets and extracellular 
matrix (Jakubovics et al., 2005a). These protein adhesins have been grouped into 
families based on similarities in sequences or structure (Nobbs, Lamont and Jenkinson, 
2009). Selected adhesin families are discussed below. 
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Important families of streptococcal adhesins are shown in Table 1.1. Most of the 
adhesins named are anchored to the cell wall with a C-terminal motif (LPxTz). This 
motif is generally followed by a hydrophobic region and a charged tail (Nobbs, Lamont 
and Jenkinson, 2009). The motif is recognised by transpeptidase sortase A, which 
cleaves the adhesin at this site and facilitates its attachment to the bacterial cell wall. 
  
32 











Plummer et al. (2005) 
Fap1 Streptococcus 
parasanguinis 
Wu et al. (1998) 
Hsa/GspB S. gordonii Jakubovics et al. (2005) 
Antigen I/II SpaP S. mutans Kelly et al. (1989) 
SspA/SspB S. gordonii Jenkinson and Demuth 
(1997) 
Fibrils CshA, CshB S. gordonii McNab et al. (1999), 
McNab et al. (1994), 
Elliott et al. (2003) 
CshA-like protein S. sanguinis Elliott et al. (2003) 
CshA-like protein Streptococcus oralis Elliott et al. (2003) 
Pili PilA, PilB, PilC S. sanguinis Okahashi et al. (2010) 
PI-2 pili S. mitis Zahner et al. (2011) 
Other PadA S. gordonii Petersen et al. (2010), 
Keane et al. (2013), 
Haworth et al. (2017) 
 
The serine-rich repeat (SRR) polypeptides are glycosylated and contain multiple blocks 
of serine-rich amino acid residues. Their N-terminal domain binds various substrata 
(Takahashi et al., 2002). The surface protein Hsa, present on S. gordonii DL1, recognises 
receptors on platelets, epithelial cells, polymorphonuclear leucocytes and immobilised 
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glycoprotein-340 (gp340) (Jakubovics et al., 2005a). Hsa orthologues are present across 
oral streptococcal species and are known to make significant contributions to virulence 
in animal models of IE (Xiong et al., 2008). Hsa has recently been shown to act 
cooperatively with another S. gordonii surface protein, PadA, in binding to platelets, 
vitronectin (Vn), salivary pellicle and in biofilm formation (Haworth et al., 2017a). 
The antigen I/II (AgI/II) family polypeptides are found across a wide range of oral 
streptococci (Jenkinson and Demuth, 1997), as well as in Streptococcus suis, 
Streptococcus agalactiae and Streptococcus pyogenes (Brady et al., 2010). These 
proteins form fibrillar structures and bind to type I collagen, fibronectin and epithelial 
cells, as well as mediating interactions with other microorganisms such as Actinomyces 
oris and P. gingivalis (Jakubovics et al., 2005b). SspA and SspB, present on S. gordonii, 
induce platelet aggregation (Kerrigan et al., 2007). 
Fibrils extend between 40 nm and 400 nm from the bacterial surface (Nobbs, Lamont 
and Jenkinson, 2009). They are fine structures, but evidence is limited regarding their 
function. S. gordonii fibril CshA is known to interact with fibronectin and other 
microorganisms (Wright et al., 2013; Back et al., 2017). 
Pili are 3-10 nm in diameter and can extend up to 3 µm from the bacterial surface 
(Nobbs, Lamont and Jenkinson, 2009). They are generally found in pathogenic 
streptococci, such as Streptococcus pneumoniae and S. pyogenes. Pili bind gp340 and 
epithelial tissues (Crotty Alexander et al., 2010; Brittan and Nobbs, 2015). They also 
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play a role in DNA-mediated transformation in S. pneumoniae (Laurenceau et al., 
2013). 
PadA is a large cell wall-anchored protein expressed on the surface of S. gordonii. The 
platelet fibrinogen receptor αIIbβ3 binds common integrin-recognition motifs within 
the N-terminal region of PadA (Keane et al., 2013). The NGR motif within PadA is 
essential for interaction of PadA with activated platelets (Haworth et al., 2017a). This 
mirrors the importance of the NGR motif in fibrinogen for interaction with platelets. 
The NGR motif is present in the D domain of fibrinogen on each of the β and γ chains 
and plays an important role in binding αIIbβ3 (Moriarty et al., 2015). 
1.5. Oral streptococcal virulence mechanisms in IE 
Most oral cavity microorganisms are commensal, but many are also opportunistic 
pathogens, capable of causing major infections under certain conditions. Oral 
streptococci can cause disease when they enter the bloodstream, such as IE (Douglas 
et al., 1993).  
1.5.1. Bacterial-endothelial cell interactions 
Bacteria need to adhere to endothelial surface components of the cardiac valve before 
they can invade and/or colonise (Vercellotti et al., 1984). Often, some alteration of the 
endocardial surface is required to allow it to be colonised (Kielhofner and Hamill, 
1989), although IE does also occur in patients with no known endocardial surface 
changes. In fact, acute endocarditis occurs on normal heart valves in at least 50% of 
cases (Ogawa et al., 1985). Bacteria, including S. aureus and VGS, have been found to 
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attach to cardiac endothelial cells in vitro (Gould et al., 1975). In addition, S. aureus 
invades and survives within endothelial cells, causing persistent infection and 
endothelial destruction (Menzies and Kourteva, 1998). Viridans streptococci 
demonstrate lower adherence to endothelial surfaces than S. aureus (Ogawa et al., 
1985) and there is evidence that VGS can invade cardiac endothelium (Stinson, Alder 
and Kumar, 2003). S. mutans has been shown to bind ex vivo human heart tissue 
(Freires et al., 2017). Although S. gordonii has been investigated for its ability to bind to 
human umbilical vein endothelial cells (HUVECs) in vitro (Vacca-Smith et al., 1994), very 
little is known regarding the mechanism of attachment and the endothelial cell ligands 
in vivo. Glucosyltransferase, Hsa, CshA and CshB have been suggested as possible 
mediators of attachment of S. gordonii to HUVECs in vitro (Stinson, Alder and Kumar, 
2003).  
1.5.2. Bacteria-extracellular matrix interactions 
The extracellular matrix (ECM) beneath the endothelium is composed of an intricate 
mixture of macromolecules, including several different types of collagen, laminin, 
fibronectin, Vn, proteoglycans and glycosaminoglycans (Zhao et al., 2016). As well as its 
structural role, the ECM is thought to be implicated in endothelial cell migration, 
proliferation and differentiation (Mintz, 2004). Physiologically, ECM proteins are 
important in the process of haemostasis (Figure 1.4). Von Willebrand factor (vWF), 
collagen and tissue factor are normally contained within the subendothelium. When a 
blood vessel is traumatised, these ECM proteins trigger primary haemostasis, where a 
platelet plug forms, quickly sealing the circulatory system, stopping further blood loss 
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and preventing pathogens from entering the circulation (Broos et al., 2011). After 
blood vessel injury, vWF, immobilised on collagen in the subendothelial tissues, 
interacts with the GPIb platelet receptor, leading to platelet rolling, slowing the 
platelet (Clemetson, 2012). When the platelet has slowed sufficiently, GPVI and GPIaIIa 
bind to collagen, leading to firm adhesion, along with GPIIbIIIa binding to vWF (Broos et 
al., 2011).  
 
Figure 1.4 Cross-section of a blood vessel showing ECM proteins important for 
haemostasis. Adapted from Bergmeier and Hynes (2012).  
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Vessel damage may expose the wide variety of ECM proteins shown in Figure 1.4. 
These may then play an important role in bacterial attachment at damaged cardiac 
endothelial sites. Fibronectin and Vn are both highly expressed on cardiac endothelium 
(Vercellotti et al., 1984). Other ECM proteins that will not be discussed in detail include 
collagen, fibrinogen, vWF, laminin, plasminogen and thrombospondin. 
Fibronectin is secreted by hepatocytes and fibroblasts. It is composed of 250 kDa 
subunits, with a large number of variants, generating molecules with different cell-
adhesive or ligand-binding properties (Schwarzbauer and DeSimone, 2011). Fibronectin 
can be classified in 2 forms according to its solubility (Pankov and Yamada, 2002): 
insoluble fibronectin is produced by fibroblasts and endothelial cells (Mao and 
Schwarzbauer, 2005) and is assembled into a matrix when deposited into the ECM; 
soluble fibronectin is produced by hepatocytes and circulates in the plasma and is 
stored in platelet α-granules.  
Adhesion to fibronectin is often an important element of bacterial virulence. 
Fibronectin-binding proteins of Gram-positive cocci allow the bacteria to adhere to 
fibronectin-containing surfaces, and may also mediate internalisation of bacteria into 
epithelial and endothelial cells (Schwarz-Linek, Höök and Potts, 2006). S. gordonii 
adhesins known to be implicated in fibronectin adhesion include CshA/CshB (McNab et 
al., 1996), Hsa (Takahashi et al., 2002), SspA and SspB (Giomarelli et al., 2006; Nobbs et 
al., 2007a; Jakubovics et al., 2009) and PadA (Haworth et al., 2017a). Fibronectin 
binding is likely to be critical in the pathogenesis of IE, since fibronectin is exposed 
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when the endothelium is injured and binds platelets and fibrin, therefore contributing 
to surface thrombogenicity (Hamill, 1987). 
Vn is contained in plasma and in the α-granules of platelets. It is also present in a 
variety of epithelial and endothelial tissues. It can play a role in stabilising thrombus 
formation and can form complexes with plasminogen activator inhibitor-1, thereby 
acting as a physiological inhibitor of active thrombin. A number of Gram-positive and 
Gram-negative bacteria have been shown to bind Vn, which can then act as a bridge 
between bacteria and epithelial cells, facilitating adhesion (Singh, Su and Riesbeck, 
2010). There is evidence that Vn is also important for streptococcal adherence to 
HUVECs (Valentin-Weigand et al., 1988). Alongside adhesion, bacterial bound Vn has 
been shown to confer serum resistance by blocking components of the complement 
system and preventing formation of the membrane attack complex (Singh, Su and 
Riesbeck, 2010). Recently, S. gordonii was shown to bind Vn via Hsa and PadA 
(Haworth et al., 2017a). This could likely augment the systemic survival of this 
bacterium.  
1.5.3. Bacteria-platelet interactions 
The primary role of platelets in the bloodstream is haemostasis after blood vessel 
injury. However, platelets are increasingly recognised as an important part of the 
innate immune response. They are ideally suited as immune response effectors 
because they are continuously in circulation. Nevertheless, platelets are thought to 
have both protective and adverse effects in infectious disease (Morrell et al., 2014). 
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Platelets bind and surround bacteria in the bloodstream, effectively hiding the invading 
bacteria from host immune components such as phagocytes. This has resulted in 
platelets being described as “Trojan Horse” carriers of bacteria in the circulation (Deng 
et al., 2014). 
Three modes of bacteria-platelet interaction have been described (Kerrigan and Cox, 
2012): 
1) Direct binding of a bacterial surface component by a receptor on the platelet 
surface. 
2) Indirect binding of a platelet receptor to bacteria through a plasma protein 
acting as a bridge, such as fibrinogen or complement. 
3) Interaction of bacterial toxins with platelets. 




Figure 1.5 Interactions between platelets and bacteria. 
A) Direct interaction 
B) Indirect interaction 




The interaction of bacteria and platelets in the bloodstream is likely to be critical for 
the formation of the infected vegetations in IE. In fact, Moreillon et al. (1988) reported 
that the ability of a streptococcal strain to adhere to a sterile vegetation (i.e. platelet 
and fibrin thrombus) is likely to be more important than the size of the bacteraemia. 
Oral streptococci selectively target platelets in whole blood over other blood 
components in vitro (Deng et al., 2014).  
Recent work has delineated the interactions of IE pathogen S. gordonii with human 
platelets. Hsa interacts with GPIb and αIIbβ3 on the platelet surface, capturing 
platelets under flow. Platelet intracellular signalling cascades are activated, including 
FcγRIIa phosphorylation. PadA then binds activated αIIbβ3, further amplifying signals 
leading to platelet shape change, thrombin production, coagulation and thrombus 
formation (Haworth et al., 2017a). SspA and SspB also interact with an unknown 
receptor on the platelet surface, stimulating platelet aggregation (Kerrigan et al., 
2007). Proposed mechanisms for the pathogenesis of S. gordonii endocarditis are 
described in Figure 1.6. 
 
Figure 1.6 Three proposed models of S. gordonii IE pathogenesis (from J. Haworth PhD thesis). 
Mechanism 1) Adhesion of S. gordonii to existing non-bacterial thrombotic endocarditis 
deposits. A) ECM is exposed in damaged heart tissue as a result of trauma or rheumatic 
fever. Platelets bind to exposed ECM proteins, such as collagen, vWF, Vn and 
fibronectin, forming a non-bacterial thrombotic endocarditis deposit. Fibronectin is 
abundant in these sterile vegetations. B) S. gordonii binds to immobilised fibronectin 
via PadA and Hsa, as well as CshA/CshB and SspA/SspB. Vn and vWF may also 
encourage S. gordonii binding to the vegetation via Hsa and PadA. Activated platelet 
surfaces present in the thrombus capture circulating S. gordonii cells via interactions of 
Hsa and PadA with GPIbα and GPIIbIIIa. PadA mediates shear resistance and Hsa and 
PadA may play a role in co-adhesion with other S. gordonii cells, contributing to growth 
of the vegetation. 
 
Mechanism 2) Adhesion of S. gordonii to immobilised fibronectin on inflamed valvular 
endothelium and subsequent mimicking of the vessel wall. 
A) Local inflammation of intact valvular endothelium results in integrin expression.  
Plasma fibronectin binds integrins and S. gordonii adheres to the immobilised 
fibronectin on the surface. B) Bacterial cells mimic host tissue and cause platelet rolling 
and subsequent platelet adhesion and activation. Subsequent invasion of endothelial 
cells by S. gordonii triggers tissue factor activity and cytokine release, encouraging 
further inflammation, coagulation and platelet clot formation. Lysis of endothelial cells 
may occur. 
 
Mechanism 3) Transport of S. gordonii cells by platelets to damaged endocardium. 
A) Circulating S. gordonii cells bind circulating platelets forming microthrombi. The Hsa-
GPIbα interaction is hypothesised to be the predominant mechanism here, although 
other bacterial platelet-interactive proteins may play a role. The platelets are effectively 
acting as Trojan Horse carriers to the damaged heart valve sites. B) Both platelet and 
bacterial receptors facilitate binding to exposed ECM factors, such as fibronectin, 
collagen, Vn and vWF.  
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1.5.4. Bacteraemia and bacterial survival in blood 
Bacteraemia can be defined as the presence of viable bacteria in the bloodstream 
(Christaki and Giamarellos-Bourboulis, 2014). The incidence of bloodstream infections 
has increased, with recent evidence from Switzerland showing a 14% increase over a 6 
year period (Buetti et al., 2017). For a bacteraemia to occur, microorganisms must first 
gain entry through either the skin or the mucosal surfaces of the oropharynx, 
gastrointestinal, genitourinary or respiratory tracts. The oral bacterial biofilm differs 
from other biofilms in that it is very close to a highly vascularised milieu. The 
subgingival epithelium, which is only 10 cell layers thick, can easily be disturbed, 
resulting in bacteraemia (Parahitiyawa et al., 2009).  
Neutrophils are one of the first and most important host defence mechanisms against 
invading microbes. Neutrophils migrate to the site of infection, with the recruitment 
mediated by chemoattractants such as interleukin-8, leukotriene B4 and granulocyte 
chemotactic protein 2 (Christaki and Giamarellos-Bourboulis, 2014). Pattern 
recognition receptors are an important part of the innate immune system. They 
recognise common microbial structures known as pathogen-associated microbial 
patterns (PAMPs). Neutrophil recognition and phagocytosis of invading 
microorganisms is facilitated by complement receptors that bind to complement and 
antibody-coated microbes. Other cells capable of phagocytosis include tissue 
macrophages, dendritic cells and natural killer cells. Neutrophil extracellular traps 
(NETs) are also likely to play a role in binding and destroying microbes. 
 
45 
Hirschfeld et al. (2017) reported that S. gordonii stimulated neutrophil reactive oxygen 
species (ROS) release and the bacteria became entrapped within NETs in an in vitro 
study. Recently, evidence has emerged that S. gordonii strains with endocarditis 
pathogenic potential can survive within macrophages at a significantly higher rate than 
strains without pathogenic potential. Survival within macrophages was due to ROS 
resistance (Croft et al., 2018). 
The complement system (Figure 1.7) is a potent host immune barrier. Complement is 
triggered after bacterial infection through either the classical, alternative or mannose-
binding lectin pathways (Christaki and Giamarellos-Bourboulis, 2014). Opsonins are 
produced, preparing microbes for phagocytosis and the generation of the membrane 
attack complex that lyses cells. The host uses regulatory proteins to avoid excessive 















Figure 1.7 Diagrammatic summary of the complement system and its pathways. 
The complement system, a humoral component of the innate immune system, 
comprises approximately 40 plasma and cell membrane-anchored proteins that act in 
a cascade-like manner to opsonise microbes and facilitate their phagocytosis, initiate 
inflammation or lyse microbes directly. Negative regulators are depicted in red.  
 
Many microorganisms take advantage of the complement system to enhance virulence 
(Walport, 2001). Bacteria such as S. aureus, S. pneumoniae and S. pyogenes target 
these regulatory proteins to escape the host immune response, as well as secreting 
proteases to degrade components of the complement system (Zipfel, Würzner and 
Skerka, 2007). One such example is the binding of S. pneumoniae PspC to Factor H (FH), 
a complement control protein and the key soluble negative regulator of C3b 

























2015). Vn is another molecule that plays an important role in serum resistance for 
many Gram-negative bacteria, including Haemophilus influenzae, Pseudomonas 
aeruginosa and Moraxella catarrhalis (Singh, Su and Riesbeck, 2010). Vn is not 
currently known to play a role in serum resistance for Gram-positive bacteria. 
Many of the factors contributing to the ability of oral bacteria to survive in the 
bloodstream are not fully understood. Roberts et al. (2006) reported that post-
procedure bacteraemia is quenched within 12 minutes following dental procedures. 
Reports prior to this study gave estimations varying between less than 5 minutes and 
more than 180 minutes for bacterial survival in blood (Guntheroth, 1984). 
1.6. Association between IE and dental procedures 
Although the links between dental procedures and bacteraemia have been known for 
many decades (Okell and Elliott, 1935), it is still not clear whether dental interventions 
cause IE (Cahill et al., 2017). The results of a recent large study suggest that invasive 
dental procedures may be associated with oral streptococcal IE, although the 
magnitude of this association remains uncertain (Tubiana et al., 2017). Undertaking 
randomised controlled trials to assess links between dental interventions and IE is 
challenging due to the rarity of the disease. As a result, a large scale observational 
study (the IDEA Study) is currently being undertaken linking NHS hospital admissions 




1.6.1. The “dentists are innocent” argument 
The relative importance of common, low-level bacteraemia compared with rare, high-
magnitude bacteraemia (such as occurs after a dental extraction) remains poorly 
defined (Cahill et al., 2017). Roberts et al. (1999) proposed that everyday transient 
bacteraemia may be more important than that caused by dental treatment with 
regards to IE risk. Cumulative bacteraemia levels are thought to be 100,000 times 
higher during physiological activities, such as flossing or chewing, than after a dental 
extraction (Que and Moreillon, 2011). The likely importance of physiological 
bacteraemia is also supported by a recent French study showing that the incidence of 
oral streptococcal IE in relation to “everyday life” bacteraemia is 94.6 per 100,000 
person years among patients with prosthetic heart valves (Tubiana et al., 2017). Only 
5% of patients with prosthetic heart valves who developed oral streptococcal IE were 
recorded as having invasive dental procedures during the 3 months prior to their 
disease presentation (Tubiana et al., 2017). This is further supported by evidence from 
animal models, where continuous low-grade bacterial infusion has been reported to be 
as infective as a single high level bolus in inducing endocarditis (Veloso et al., 2011).  
1.6.2. IE related to orthodontics 
It is very likely that patients at risk of IE will present for orthodontic treatment. The 
majority of orthodontic patients present between the ages of 10 and 16, when the 
incidence of IE is highest in children (Hobson and Clark, 1995). Nevertheless, 
orthodontically-induced IE is likely to be very rare. Three case reports in total have 
been published regarding orthodontic treatment-associated IE. Two case reports were 
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published by Biancaniello and Romero in 1991, describing a 13-year old boy and a 14-
year old girl who developed IE caused by Haemophilus parainfluenzae and a viridans 
group Streptococcus respectively. Both patients had received an orthodontic 
adjustment 10 days prior to their disease presentation and neither had undergone any 
other dental procedures for at least 6 months (Biancaniello and Romero, 1991). In 1993 
a further case report was published, describing a 19 year-old with a ventricular septal 
defect who developed S. mitis endocarditis, 10 months after the commencement of 
orthodontic treatment and 2 weeks after an archwire change and application of 
powerchain (Hobson and Clark, 1993).  
In 1995, the results of a survey of orthodontists were published, reporting that 8 cases 
of IE associated with orthodontic treatment had occurred over a 44 year period 
(Hobson and Clark, 1995). Others have estimated that an orthodontist would need to 
practise for more than 1000 years before being implicated in causing one case of IE 
(Roberts, Lucas and Omar, 2000). Twelve percent of orthodontists surveyed in the UK 
had refused orthodontic treatment for at-risk patients. The authors concluded that it 
was good practice to inform those patients at risk about the possibility of IE arising 
during orthodontic treatment (Hobson and Clark, 1995). These papers have been 
useful in showing an association between orthodontic treatment and IE, but causation 
is difficult to prove, especially in light of the more recent debate regarding bacteraemia 
arising following physiological activities versus dental treatment. Burden et al. (2001) 
postulated that the relationship between orthodontic treatment and endocarditis was 
more likely to be coincidental rather than causal. Orthodontic treatment also presents 
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particular challenges when assessing causation due to the progressive, long-term 
nature of the treatment in comparison to other dental specialties (Degling, 1972). 
Nevertheless, the time-course indicated in the case reports described does suggest a 
relationship. 
Studies have attempted to identify which orthodontic procedures are most likely to be 
linked with bacteraemia and the results have been conflicting (Khurana and Martin, 
1999). No bacteraemia was identified following banding and debanding in a study by 
Degling (1972), but Burden et al. (2004) found a bacteraemia prevalence of 13% when 
brackets and bands were removed. Bacteraemia incidence after orthodontic band 
placement has been reported as 7.5% and 10% in different studies (McLaughlin et al., 
1996; Erverdi et al., 2000). It has also been highlighted that even when no obvious 
bleeding was detected clinically, post-operative bacteraemia can be detected 
(McLaughlin et al., 1996). Further investigations have been carried out to assess 
incidence of bacteraemia following mini-implant insertion (1 in 40, Uysal et al., 2010), 
mini-implant removal (no bacteraemia, Livas et al., 2013), orthodontic stripping (1 in 
29, Yagci et al., 2013), gold chain adjustment (no bacteraemia, Lucas et al., 2007), 
piezocision (1 in 10, Ileri et al., 2014) and removal of Haas palatal expanders (1 in 2, 
Rosa et al., 2005). Many of these studies provide conflicting evidence and often the 
sample sizes are small. There may also be limitations associated with the methodology 
in these papers. Broth culture is often used, allowing the percentage prevalence of 
positive blood culture to be recorded. However, this technique is unable to provide 
information regarding the number of bacteria in the blood sample that was originally 
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taken. The lysis filtration method can provide both an estimate of the prevalence as 
well as the intensity of the bacteraemia. 
The lysis filtration technique was used by Lucas et al. (2002) to identify bacteraemia 
prevalence and intensity after a number of orthodontic procedures, including alginate 
impressions, separator placement, band placement and fixed appliance archwire 
adjustment. Separator placement was the only intervention that resulted in a 
significant bacteraemia. A further study confirmed that bacteraemia occurred following 
separator placement and that viridans group Streptococcus bacteria were the 
predominant isolates, alongside S. aureus (Umeh et al., 2016). Lucas et al. (2002) 
reported on the bacteria most commonly found in blood cultures following orthodontic 
procedures, with 65% being coagulase-negative staphylococci and 9% being oral 
streptococci, with Streptococcus vestibularis, S. mitis, S. salivarius, S. gordonii and S. 
sanguinis making up this group. S. sanguinis has also been detected following insertion 
of mini-implants and orthodontic stripping (Uysal et al., 2010; Yagci et al., 2013). 
Piezocision and removal of Haas palatal expanders have both been associated with S. 
oralis bacteraemia (Rosa et al., 2005; Ileri et al., 2014). 
Orthodontic treatment-related bacterial colonisation of a non-cardiac site has also 
been reported. A brain abscess due to Haemophilus aphrophilus (a Gram-negative 
bacillus and a component of dental plaque) occurred in a 12 year-old boy. He had 
started fixed appliance therapy 6 weeks prior and had received a fixed appliance 
adjustment two weeks prior to disease presentation. The authors of the case report 
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postulated that this was due to transient bacteraemia as a result of the orthodontic 
appliance manipulation and that a patent foramen ovale had allowed the bacteria to 
enter the cerebral circulation (Wolf and Curtis, 2008). 
1.6.3. Clinical guidelines regarding dentistry and bacteraemia risk 
The clinical management of patients at risk of IE undergoing dental procedures has 
been a controversial topic for several years. NICE issued guidelines in 2008 
withdrawing the prescription of antibiotic prophylaxis for patients at risk of IE 
undergoing dental procedures. A large longitudinal study showed an increase in 
incidence of IE cases after this change in practice (Dayer et al., 2015). However, 
limitations of this study included the fact that data were obtained from hospital coding 
and that it was not possible to distinguish between the effects of subtle changes in the 
population due to immigration or other health policy from the overall trend. It should 
also be stressed that the association between IE incidence and reduced antibiotic 
prescriptions was not necessarily causal. Nevertheless the results of this study were a 
trend mirrored by increased incidence of IE in some studies from the USA and 
Germany. These rises in incidence had occurred after implementation of American and 
European guidelines (2007 and 2009/2015 respectively), recommending antibiotic 
prophylaxis only be given in patients with prosthetic heart valves, a history of IE or with 
a congenital cyanotic heart disease undergoing invasive dental procedures (Wilson et 
al., 2007; Habib et al., 2009; Habib et al., 2015).  
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NICE reviewed their guidelines in 2015 and reported that there was insufficient 
evidence to warrant a change, stimulating considerable debate in the literature 
(Alderson and Baker, 2016; Chambers et al., 2016a; Chambers et al., 2016b; Million et 
al., 2016; Thornhill et al., 2016c; Thornhill et al., 2016d). In July 2016, there was a 
change in the wording of the NICE guidelines, meaning that in individual cases, 
antibiotic prophylaxis may be appropriate (NICE 2008, updated 2016). This leaves 
considerable challenges for the dental profession in implementation of the guidelines 
(Thornhill et al., 2016a), but recent publication of “Implementation Advice for National 
Institute for Health and Care Excellence (NICE) Clinical Guideline 64 Prophylaxis 
Against Infective Endocarditis” by the Scottish Dental Clinical Effectiveness 
Programme has been welcomed. It is the orthodontist’s responsibility to liaise 
carefully with patients’ physicians and other healthcare professionals to act in 
the patient’s best interests, whilst adhering to the principles of informed 
consent, as described in the Montgomery case in 2015 (Main and Adair, 2015).  
1.6.4. Clinical guidelines regarding orthodontics and bacteraemia risk 
Good guidelines for the management of orthodontic patients at risk of IE have been 
lacking or conflicting (Khurana and Martin, 1999). The current discrepancies in 
guidelines for antibiotic prophylaxis for patients undergoing dental procedures across 
different parts of the world complicate the picture. Although performed before the 
change in NICE guidelines, a study in the field of IE risk management in the UK found 
that compliance is often compromised when complex, conflicting guidelines exist. The 
need for simple, unambiguous guidelines was highlighted (Chate, 2008). In America, 
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there is confusion about which orthodontic procedures are most prone to generate 
bacteraemia amongst orthodontists (Leong, Kunzel and Cangialosi, 2012). 
In addition to identifying patients who may benefit from antibiotic prophylaxis, the use 
of antimicrobial mouth rinses has also been proposed for some orthodontic patients. 
Chlorhexidine gluconate-based mouth rinses may be beneficial in temporarily reducing 
bacterial load prior to placement or removal of bands (Sonis, 2004). A more recent 
study by Dua et al. (2016) found that the use of a chlorhexidine rinse immediately prior 
to separator placement resulted in no bacteraemia being detected post-procedurally. 
However, this study was flawed due to the lack of a control group. 
Orthodontists have a major role to play in surveillance and education. They may be the 
only health care professionals that fit and healthy young individuals see on a regular 
basis. The orthodontic profession therefore has a duty of care in education, prevention 
and early detection of IE. The following suggestions have been made for orthodontists 
treating patients at risk of IE (Patel, Burden and Sandler, 2009): 
- The orthodontic team should stress the importance of good general dental 
and skin hygiene  
- Communication with the patient’s physician enables the orthodontist to 
understand the risk of IE for each susceptible patient 
- Orthodontists should provide information about the signs and symptoms 
that may indicate IE and when to seek specialist advice 
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- The use of orthodontic bands and fixed acrylic appliances should be 
avoided in high risk patients with poor oral hygiene 
- There should be prompt referral, investigation and treatment of any 
episode of infection 
These principles are mirrored in the British Orthodontic Society’s guidelines for the 
management of patients at risk of IE (BOS, 2016), where it is stipulated that if in doubt, 
the orthodontist should always contact the patient’s cardiac specialist.  
1.7. Summary and implications for further research 
Although rare, infection-induced cardiovascular disease has high mortality and 
morbidity rates and places a large burden on society. There is a lack of understanding 
regarding the mechanisms underlying survival and virulence of oral streptococci in the 
bloodstream, both critical prerequisites for streptococcal IE. Oral streptococcal blood 
survival mechanisms may represent putative targets for the prevention or treatment of 
IE. To develop this strategy, a detailed understanding of the molecular basis of survival 
of oral streptococci in blood is required. Critical questions are: 
▪ How long do oral streptococci survive in the blood? 
▪ Do oral streptococci modulate the host complement system to survive in 
blood? 
▪ What bacterial factors are important in evasion of host defences? 
▪ Are streptococcal survival mechanisms likely to be applicable across other 
endocarditis pathogens? 
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▪ What are the implications of these findings for the management of orthodontic 
and paediatric patients at risk of IE in the context of the current regimes in the 
UK?  
1.8. Aims and Objectives 
The overall aim of this project was to study the blood survival mechanisms of 
microorganisms commonly implicated in orthodontic separator placement, with a 
particular focus on oral streptococci. This project will therefore help to develop a 
mechanistic understanding of streptococcal virulence in bacteraemia and IE. 
The specific objectives were to: 
- Identify, from published literature, relevant oral streptococci for use in blood 
survival studies 
- Determine the time course of survival for different oral streptococci in blood 
- Investigate the role of bacterial surface determinants in promoting 
streptococcal survival in blood 
- Characterise interactions of oral streptococci with complement factors relevant 




2. Materials and Methods 
2.1. Growth conditions 
Streptococcal strains were grown in Brain Heart Infusion broth supplemented with 
0.5% Yeast Extract (BHY) at 37 °C in reduced oxygen conditions. Lactococcal strains 
were grown in Brain Heart Infusion broth supplemented with 0.5% Yeast Extract 
(BHY) at 30 °C in reduced oxygen conditions. Where required, media were 
supplemented with antibiotics at the following concentrations: erythromycin, 5 




Table 2.1 Bacterial strains used in this project 








S. gordonii DL1 Wild-type, 
parental strain 
Challis 
1507 Le Blanc, Lee 
and Inamine, 
1991  




S. salivarius NCTC 8606 Wild-type 384 Willers, Ottens 
and Michel, 
1964  
S. oralis NCTC 11427 Wild-type 2178 Ronda, García 
and López, 1988 



















S. gordonii DL1 ∆padC  2889 Laboratory 
strain 





S. gordonii DL1 ∆padB  2833 Laboratory 
strain 
S. gordonii DL1  ∆hsa  2930 Laboratory 
strain 
S. gordonii DL1 ∆sndA  2827 Laboratory 
strain 
S. gordonii DL1 ∆sortase A  2576 Nobbs et al., 
2007b 
S. gordonii  
 




S. gordonii  
 
DL1 ∆padA::aad9 2723 Haworth et al., 
2017a  
S. gordonii  DL1 ∆padA::aad9-
pMSP-padA 
2724 Haworth et al., 
2017a  











MG1363 Wild-type Lac- 754 Gasson, 1983  
 
2.2. Whole blood preparation 
Informed consent was obtained and whole blood was collected from the 
antecubital fossa of healthy volunteers who were either staff or students of the 
University of Bristol. In total, 11 volunteers donated blood for this project. Varying 
numbers of donors were used for each individual experiment. The ethical approval 
is described in 2.12 below. Exclusion criteria included pregnancy, medical 
treatment, current medication, being below the age of 18 and feeling unwell. The 
blood was collected into 10 ml plastic vacutainer bottles containing K2EDTA (Fisher 
Scientific, Loughborough, UK) and inverted 10 times to ensure thorough mixing with 
the anticoagulant. 
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2.3. Bacterial blood or serum survival assay 
Bacterial cultures (10 ml) were grown overnight at 37 °C in a candle jar and cells 
harvested by centrifugation (5000 x g, 7 min) using a Rotina 380 benchtop 
centrifuge (Hettich, Massachusetts, USA). Cells were washed once in PBS 
(phosphate buffered saline) and adjusted in PBS to OD600 1.0 (equivalent to 1x109 
cells/ml). Anticoagulated human blood (90 µl) or human serum (90 µl, CS500-100, 
TCS Biosciences, Buckingham, UK) was added to the wells of a 96-well plate. PBS or 
adjusted cell suspension (10 µl) was added to the appropriate wells and mixed. 
Microtitre plates were incubated in a candle jar at 37 °C for 0, 2, 4 or 6 h at 80 rpm. 
The bacteria/blood or bacteria/serum suspensions were serially diluted in PBS and 
aliquots (10 µl) plated onto agar plates. The plates were incubated for 24 h at 37 °C 
in a candle jar and the colony forming units counted. 
2.4. Immunodot blot analysis 
Bacterial suspension (2 µl), adjusted to OD600 1.0 in PBS, was placed onto 
nitrocellulose and the membrane allowed to air dry. The blot was blocked in 5% 
BSA in TBST (Tris-buffered saline [TBS; 10 mM Tris-HCl pH 7.5, 100 mM NaCl] 
supplemented with 0.1% Tween-20) overnight at 4 °C. The membrane was washed 
twice in TBST (50 ml, 10 min). FH was detected by probing the nitrocellulose 
membrane with mouse anti-human FH antibody (1 in 1000 dilution, Biorad, 
Watford, Hertfordshire) in TBST (45 min) followed by washing in TBST (15 min) and 
two further washes in TBST (5 min). The membrane was probed with goat anti-
mouse horseradish peroxidase-conjugated antibody (1 in 2000 dilution, Dako, Santa 




washes in TBST (5 min). The blot was incubated with enhanced chemiluminescence 
Western blot detection reagent (GE Healthcare, Amersham, Buckinghamshire, UK) 
and exposed to film in the dark and subsequently developed. Densitometry analysis 
of immunodot blots was performed using Image Quant TL software (GE Healthcare, 
Amersham, Buckinghamshire, UK). 
2.5. Bacterial binding assay to FH in human serum 
Bacterial cultures (10 ml) were grown overnight at 37 °C in a candle jar and cells 
harvested by centrifugation (5000 x g, 7 min). Cells were washed once in PBS+ (PBS 
supplemented with 1 mM CaCl2 and 1 mM MgCl2) and adjusted to OD600 1.0. The 
bacterial suspension (1 ml) was centrifuged (5000 x g, 7 min) and the cell pellet 
resuspended in 10% human serum (TCS Biosciences CS500-100; 1 ml; diluted in 
PBS+) and incubated with gentle agitation at 37 °C (30 min). The bacterial 
suspension was incubated on ice (1 min) to inhibit complement activation. Bacterial 
cells were harvested by centrifugation (13000 g, 4 °C, 5 min), washed once in PBS+ 
then resuspended in PBS containing 0.05% (v/v) sodium azide for analysis by 
immunodot blot assay. FH binding was detected by probing with primary antibody 
(mouse anti-human FH, 1 in 1000 dilution, Biorad) and secondary antibody (goat 
anti-mouse horseradish peroxidase-conjugated, 1 in 2000 dilution, Dako). Reactivity 
was detected as described for immunodot blot analysis. 
2.6. Crystal violet bacterial binding assay to human FH  
Human FH (50 μl, 20 µg/ml final concentration, Merck, Darmstadt, Germany), 
diluted in coating buffer (20 mM Na2CO3, 2 mM NaHCO3, pH 9.3), was added to 
wells of a high-binding 96-well plate (Immulon 2HB, Thermo Scientific) and 
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incubated overnight at 4 °C. Wells were washed once in 200 μl TBSC (10 mM Tris-
HCl [pH 7.6], 150 mM NaCl, 5 mM CaCl2), and non-specific binding sites blocked 
with 3% (w/v) BSA in TBSC containing 0.05% (v/v) Tween-20 for 1 h at 37 °C. 
Bacterial cultures (10 ml) were grown overnight at 37 °C (streptococci) or 30 °C 
(lactococci) in a candle jar and cells were harvested by centrifugation (5000 x g, 7 
min). Bacterial cells were washed once in TBSC (5 ml) and the suspension adjusted 
in TBSC to OD600 1.0. The adjusted cell suspension (100 μl) was added to the wells 
and incubated at 37 °C for 2 h. Following removal of the suspension, the wells were 
washed twice in TBS (200 μl). Adherent cells were fixed by adding 25% (v/v) 
formaldehyde (100 μl) for 30 min at room temperature. Wells were washed twice in 
TBS (200 μl) before adding 0.5% (w/v) crystal violet (100 μl) and incubating for 2 
min at room temperature. Wells were washed three times in TBS before adding 
10% (v/v) acetic acid (100 μl) and incubating at room temperature for 5 min. Levels 
of adhesion were quantified by measuring absorbance at 595 nm.  
2.7. Binding of bacteria to pure FH 
Bacterial cultures (10 ml) were grown overnight at 37 °C (streptococci) or 30 °C 
(lactococci) in a candle jar and cells were harvested by centrifugation (5000 x g, 7 
min). Bacterial cells were washed once in PBS+ and the suspension adjusted in PBS+ 
to OD600 1.0. Bacterial cells were harvested by centrifugation (13800 x g, 5 min), 
resuspended in human FH (500 µl, diluted in PBS+ to 50 µg/ml, Merck) and 
incubated with gentle agitation (1 h, 37 °C). Cells were washed twice in PBS+ (5 ml), 
resuspended in 0.2 M glycine-HCl (2.5 ml, pH 2.6) and incubated at room 




centrifuged (13800 x g, 5 min), the supernatant collected, and the pH adjusted to 
pH 7 by the addition of Tris-HCl (1 M, pH 8.0, 1 ml). The solution was concentrated 
10-fold in a refrigerated Centrivap concenthumarator (LabConco, Kansas City, USA), 
and the concentrated solution (2 µl) placed onto a nitrocellulose membrane and 
allowed to air dry. The presence of FH was detected by immunodot blot analysis, as 
described above (2.4). 
2.8. Recombinant protein FH binding ELISA 
Human FH (50 μl, 20 µg/ml, Merck), diluted in coating buffer, was added to wells of 
a high-binding 96-well plate (Immulon 2HB) and incubated overnight at 4 °C. Wells 
were washed once in 200 μl TBSC and non-specific binding sites blocked with 3% 
(w/v) BSA in TBSC (200 μl) for 1 h at 37 °C. Wells were washed once in TBSC (200 μl) 
before recombinant protein (1, 2 or 5 μg, 50 μl final volume), diluted in TBSC, was 
applied to the wells and incubated for 1 h at 37 ⁰C. Unbound protein was removed 
and wells washed once in TBS (200 μl). Primary antibody (mouse anti-tetraHis, 50 
μl, Qiagen, Manchester, UK), diluted 1 in 1000 into TBST, was added to the wells 
and incubated for 1 h at 37 ⁰C. Wells were washed twice in TBST (200 μl) before 
adding secondary antibody (goat anti-mouse HRP, diluted 1 in 2000 into TBST 
containing 3% [w/v] BSA, 50 μl, Dako) and incubating for 1 h at 37 ⁰C. Wells were 
washed once in TBST (200 μl) and then twice in TBS (200 μl). ELISA reagent (0.102 
M Na2HPO4, 0.049 M citric acid, 0.012% H2O2, 3.7 mM O-phenylenediamine; 50 μl) 
was added to wells and incubated in the dark for 10 min at room temperature. 
H2SO4 (0.65 M, 50 μl) was added to stop the reaction. Levels of adhesion were 
quantified by measuring absorbance at 490 nm.  
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2.9. ELISA to detect binding of FH to native PadAHis6 or HsaHis6 on Ni-NTA 
HisSorb strips 
Ni-NTA HisSorb strip wells (Qiagen) were coated with native PadAHis6 (200 µl, 100 
µg/ml) or HsaHis6 (200 µl, 100 µg/ml) in TBS containing 3% (w/v) BSA and incubated 
at room temperature for 1 h. Wells were washed four times in TBSC (200 µl) and FH 
(200 µl, 5 µg/ml, Merck), diluted in TBST containing 3% (w/v) BSA, was added to 
wells and incubated at room temperature (37 °C, 1 h). The remainder of the assay 
was performed as described in section 2.8 above. All incubation steps were 
performed at 90 rpm.  
2.10. Crystal violet bacterial binding assay to human Vn 
Multimeric Vn (5 µg/ml final concentration, Merck) was diluted in coating buffer (20 
mM Na2CO3, 2 mM NaHCO3, pH 9.3) and incubated with mAb 8E6 (10 µg/ml, Sigma, 
Darmstadt, Germany) for 1 h (37 °C, 50 rpm). Multimeric Vn (5 µg/ml final 
concentration, Merck), diluted in coating buffer, or multimeric Vn that had been 
pre-incubated with mAb 8E6, was added to wells of a high-binding 96-well plate 
(Immulon 2HB) and incubated overnight at 4 °C. Wells were washed once in 200 μl 
TBSC and non-specific binding sites blocked with 3% (w/v) BSA in TBSC containing 
0.05%(v/v) Tween-20 for 1 h at 37 °C. Bacterial cultures (10 ml) were grown 
overnight at 37 °C (streptococci) or 30 °C (lactococci) in a candle jar and cells were 
harvested by centrifugation (5000 x g, 7 min). The crystal violet binding assay was 





2.11. ELISA to detect binding of Vn to immobilised S. gordonii DL1 WT 
cells 
Multimeric Vn (5 µg/ml final concentration, Merck), diluted in TBSC, was incubated 
with heparin (final concentration 180 µg/ml, Sigma) for 1 h (37 ⁰C, 50 rpm). S. 
gordonii DL1 WT bacterial cells from overnight culture were washed, resuspended 
to OD600 1.0 and immobilised in microtitre plate wells. Wells were washed once in 
200 μl TBSC and non-specific binding sites blocked with 3% (w/v) BSA in TBSC (200 
μl) for 1 h at 37 ⁰C. Wells were washed once in TBSC (200 μl) before multimeric Vn 
(5 µg/ml final concentration, Merck), diluted in TBSC, or multimeric Vn that had 
been pre-incubated with heparin (5 µg/ml final concentration), was applied to the 
wells and incubated for 1 h at 37 ⁰C. Unbound protein was removed and wells 
washed once in TBS (200 μl). Primary antibody (50 μl, mouse anti-human Vn, Santa 
Cruz Biotechnology, Texas, USA), diluted 1 in 1000 into TBST, was added to the 
wells and incubated for 1 h at 37 ⁰C. Wells were washed twice in TBST (200 μl) 
before adding secondary antibody (goat anti-mouse HRP, diluted 1 in 2000 into 
TBST containing 3% [w/v] BSA, 50 μl, Dako) and incubating for 1 h at 37 ⁰C. The 
remainder of the assay was performed as described in 2.8.  
2.12. Ethical approval 
Ethical approval was gained from the University of Bristol Health Sciences Faculty 
Research Ethics Committee (application number 54322) for obtaining blood from 
University of Bristol staff and student volunteers under the study title 
“Understanding the link between oral microbes and systemic disease”.  
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2.13. Statistical analysis 
Statistical analyses were performed using SPSS (IBM) or Excel (Microsoft Office 365 
Plus). Data shown are the mean ± standard error of the mean (SEM). Unless 
otherwise stated, experiments were performed in triplicate. Comparisons between 
the means were performed using the Student’s 2-tailed unpaired t test or, where 
multiple samples were compared, by ANOVA followed by the Tukey test. Individual 
data points are shown for blood survival studies in scatter plots and different blood 
donors are depicted by different colours. Comparisons between strains for the 
blood survival data were performed using the Wilcoxon signed ranks test or, where 
multiple samples were compared, by the Friedman test. For all data shown, a P 





3.1. Survival of bacteria in human blood 
The ability of bacteria to survive in the bloodstream is likely to be critical for IE 
pathogenesis. Estimations of duration for bacterial survival in blood have varied 
between less than 5 minutes to more than 180 minutes (Guntheroth, 1984; Roberts 
et al., 2006), and it is possible that IE disease risk may be directly related to the 
length of time bacteria can survive. Initial studies therefore aimed to investigate the 
time course of bacterial survival in human whole blood. Oral viridans group S. 
gordonii is an important cause of IE and was used as a reference species in these 
initial investigations. This microorganism colonises most surfaces in the oral cavity 
and its virulence mechanisms in IE have been widely investigated (Keane et al., 
2010; Petersen et al., 2010; Haworth et al., 2017a). 
Fresh human whole blood was selected for use in these in vitro studies to provide 
the most relevant experimental conditions possible. Initially, the ability of S. 
gordonii to survive in human blood was compared to that of L. lactis. L. lactis is a 
Gram-positive bacterium commonly used as a heterologous expression host for 
Gram-positive surface proteins. L. lactis does not colonise human tissues naturally 
and is a ‘generally regarded as safe’ (GRAS) species, making it a suitable negative 
control. Following 2 h incubation in human blood, bacteria were recovered and the 
numbers of viable cells determined by measurement of colony-forming units grown 











Figure 3.1 Appearance of colony-forming units on agar plate, divided into 6 
sections according to serial dilution. See Methods 2.3. The plates were incubated 
for 24 h at 37 ℃ in a candle jar and the colony-forming units counted.  
 
Survival at 2 h is presented as a percentage of the initial inoculum in Figure 3.2. 
After 2 h, L. lactis was reduced in survival compared to S. gordonii for both donors, 















Figure 3.2 Percentage survival of wild-type S. gordonii and L. lactis bacterial cells 
incubated in human whole blood for 2 h. See Method 2.3. Each coloured line 
connecting data points indicates data from individual donors. P=NS as determined 















































S. gordonii DL1 L. lactis MG1363  
NS 
70 
S. gordonii was further investigated for ability to survive over a 6 h time course in 
human blood (Figure 3.3). Percentage survival reduced between 2 h and 4 h for all 
















Figure 3.3 Percentage survival of wild-type S. gordonii incubated in human whole 
blood over 6 h. See Method 2.3. Each coloured line connecting data points 
indicates data from individual donors. P=NS as determined by Friedman test and 
post-hoc analysis with Wilcoxon signed-rank tests (with Bonferroni correction 
applied). n=7. 
Other streptococcal endocarditis pathogens were selected for comparison with S. 
gordonii. Gram stain micrographs of the strains selected are shown in Figure 3.4 and 















































Figure 3.4 Representative Gram stains of streptococcal strains used in this project, showing no evidence of sample contamination
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IE pathogen S. oralis was selected as a second member of the mitis group of 
streptococci, alongside S. gordonii. After 2 h incubation, S. oralis CR843 showed 
slightly lower or similar survival percentages and S. oralis NCTC 11427 increased 
survival percentages compared to S. gordonii DL1 for 3 out of the 4 donors. One 
donor showed increased survival for S. oralis CR843 and decreased survival for S. 
oralis NCTC 11427 compared to S. gordonii DL1 (Figure 3.5). Overall, the differences 
between the strains were not statistically significant.
 
Figure 3.5 Percentage survival of S. gordonii and S. oralis strains incubated in 
human whole blood for 2 h. Method 2.3. Each coloured line connecting data 
points indicates data from individual donors. P=NS (not significant) as determined 





S. sanguinis is closely related to S. gordonii and, while often isolated in abundance 
from health-associated microbial communities (Nobbs and Kreth, 2019), has the 
potential to cause IE (Do et al., 2011). Strains S. sanguinis 1330 and 2017-78 were 
chosen for investigation, with the latter being isolated from a confirmed case of 
subacute bacterial endocarditis (Herzberg, Brintzenhofe and Clawson, 1983). Two 
out of 3 donors showed increased survival for S. sanguinis SK36 compared to S. 
gordonii DL1. S. sanguinis 2017.78 survived at levels either slightly greater or 






Figure 3.6. Percentage survival of S. gordonii and S. sanguinis incubated in human 
whole blood for 2 h. Method 2.3. Each coloured line connecting data points 
indicates data from individual donors. P=NS (not significant) as determined by 













































S. sanguinis 2017.78 
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S. salivarius is a member of the salivarius group of streptococci and has no strong 
association with cardiovascular disease. S. salivarius NCTC 8606 showed reduced 
survival levels compared to S. gordonii DL1 for all donors. S. mitis NCTC 12261, a 
third member of the mitis group of streptococci and a known causative agent of IE 
was also reduced in survival compared to S. gordonii DL1 at 2 h (Figure 3.7).  
Figure 3.7 Percentage survival of S. gordonii, S. mitis and S. salivarius incubated in 
human whole blood for 2 h. Method 2.3. Each coloured line connecting data 
points indicates data from individual donors. P=NS (not significant) as determined 
by Kruskal Wallis test; n=3 (S. mitis NCTC 12261, n=2, as bacteria failed to grow for 




Taken together, these data showed that survival in human blood by oral 
Streptococcus bacteria was species- and strain-dependent, with those associated 
with IE demonstrating a general trend of greater capacity to withstand clearance. 
Of the VGS that were tested, survival levels were all comparable or lower than 
those of S. gordonii. This validated the use of S. gordonii as the model strain for 
exploring in greater detail the mechanistic basis for survival in blood.  
3.2. Interaction with complement cascade mediators 
The complement system, an important component of the innate immune response, 
comprises many plasma proteins that act in a cascade-like manner. To prevent the 
host’s own activated complement causing unintended injury to self cells, it is critical 
that host cells have a number of proteins capable of down-regulating the 
complement cascade. A set of plasma proteins including FH, Vn, factor I, C4BP and 
C1 have a pivotal role in preventing complement activation in host tissues.  
3.2.1. Interaction with FH 
FH is a conserved plasma glycoprotein that inhibits the alternative complement 
pathway and the C3b amplification loop. It has a molecular weight of ~150 kDa, and 
is synthesised by hepatocytes and secreted into the blood at concentrations up to 
500 µg/ml. The FH molecule comprises 20 complement control protein domains, 
with the regulatory activities of FH being mediated by N-terminal domains 1-4, 
which include a C3b-binding site (Jozsi, 2017). The C-terminal domains anchor the 
molecule to host surfaces with deposited C3b (Jozsi, 2017), enabling FH to protect 
the cells from complement-mediated damage. Several microbes are known to 
exploit this mechanism and recruit FH to the microbial surface to escape 
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complement-mediated killing, including S. pneumoniae (Janulczyk et al., 2000) and 
N. meningitidis (Pizza, Donnelly and Rappuoli, 2008). Unpublished mass 
spectrometry data (Lohiya, 2018) had suggested that two large cell surface-
anchored proteins of S. gordonii, PadA and Hsa, were able to interact with FH from 
human serum. Possible binding of PadA or Hsa to FH was therefore investigated 
further as a putative mechanism for enhancing S. gordonii survival in blood. 
Initially, Hsa and PadA proteins, purified from S. gordonii, were investigated for 
ability to bind FH directly. S. gordonii strains UB2870 ∆padA/pMSP-padA-His-term 
and S. gordonii UB2935 ∆hsa/pMSP-hsa-His-term, which secrete native forms of 
PadA or Hsa, respectively, carrying a C-terminal His6 tag (PadAHis6 or HsaHis6), had 
been previously generated. These strains were cultured in FMC medium 
supplemented with nisin (100 ng/ml) to induce expression and secretion of PadAHis6 
or HsaHis6 into the culture medium. This was subsequently recovered and the 
protein purified using nickel affinity chromatography. To investigate binding of 
PadAHis6 or HsaHis6 to purified FH, an ELISA assay was performed. PadAHis6 or HsaHis6 
were immobilised onto Ni2+-coated microtitre wells, before detecting purified FH 
bound from solution with anti-FH antibody. These assays showed significant binding 
by FH to PadAHis6 and HsaHis6 when compared to the buffer only control (Figures 3.8 














Figure 3.8 FH adhesion to immobilised PadAHis6 was determined by ELISA. FH 
binding was detected by mouse anti-FH antibody (1:1000 dilution) and secondary 
anti-mouse HRP antibody (1:2000 dilution). ELISA reagent was added and 
absorbance read at 490 nm. Error bars indicate SD. *P=0.01 as determined by 









Figure 3.9 FH adhesion to immobilised HsaHis6 was determined by ELISA. FH 
binding was detected by mouse anti-FH antibody (1:1000 dilution) and secondary 
anti-mouse HRP antibody (1:2000 dilution). ELISA reagent was added and 
absorbance read at 490 nm. Error bars indicate SD. *P<0.01 as determined by 
Student’s t test; n=2. 
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Having established the capacity for FH to directly interact with either PadA or Hsa, it 
was then important to investigate if this binding occurred on the surface of S. 
gordonii cells. For these assays, binding by wild-type (WT) S. gordonii was compared 
to a range of knockout mutants: ΔpadA (UB2864), Δhsa (UB2930) and ΔsrtA 
(UB2576). In S. gordonii, membrane-associated transpeptidase sortase A (SrtA) is 
responsible for covalently anchoring a major family of proteins (LPxTG family) to 
the cell surface, including PadA and Hsa (Paterson and Mitchell, 2004; Davies, 
Svensäter and Herzberg, 2009). By including the srtA mutant (UB2576) in these 
assays, it was therefore possible to investigate the effect of removing all LPxTG-
family proteins from the surface of S. gordonii. L. lactis MG1363 (UB754) was 
included in these experiments as a negative control. 
Binding of bacterial cells to immobilised FH was detected by crystal violet assay. 
Measurement of absorbance at 595 nm allowed quantification of bacterial 
adhesion levels. S. gordonii WT was found to bind immobilised purified FH only at 
low levels. S. gordonii ΔpadA was reduced by 30%, but this was not statistically 
significant. L. lactis was significantly reduced by 52% with an even greater reduction 
of 73% and 80% seen for S. gordonii Δhsa and ΔsrtA respectively (Figure 3.10). 
However, as the levels of binding displayed in these studies were extremely low and 
at the limit of detection for this assay, it was considered that these data should be 
interpreted with caution. As such, an ELISA technique was also employed to detect 
the capacity for immobilised bacteria to bind FH from solution. This resulted in high 
background readings, possibly as a result of non-specific binding by antibody to 






Figure 3.10 Adhesion of S. gordonii DL1 WT and isogenic mutants to immobilised 
FH (20 µg/ml) over 2 h was determined by crystal violet assay. Background 
readings for wells with no cells have been subtracted. Error bars indicate SEM. 
*P<0.05, NS=not significant relative to S. gordonii WT as determined by one-way 
ANOVA and post-hoc Tukey test; n=3.  
An alternative approach to investigating the ability of bacterial cells to bind purified 
FH was adopted, based on the method of Gustafsson et al. (2013). Further strains 
were also included for investigation: the complemented versions of S. gordonii Δhsa 
and ΔpadA knockout strains and two versions of the ΔpadA knockout mutant that 
had been constructed using different mutagenesis approaches: S. gordonii 
∆padA::aad9 (UB2723), which is the parent strain for complemented mutant 
(UB2724), and S. gordonii ∆padA (UB2864). For the complemented strains, 
expression of hsa or padA is under the control of a nisin-inducible promotor. The 
first step with these investigations was therefore to confirm expression of PadA or 
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Hsa by the complemented strains when cultured in medium supplemented with 
100 ng/ml nisin. Immunodot blot analysis confirmed nisin induction of expression 
and validation of the knockout mutants (Figure 3.11). The anti-PadA serum showed 










Figure 3.11 Immunodot blot confirming expression of Hsa and PadA by S. gordonii 
knockout and complemented mutant strains. Overnight broth cultures (2 µl) were 
spotted onto nitrocellulose and allowed to air dry. The presence of Hsa (A) or 
PadA (B) was detected by immunodot blot analysis using anti-Hsa primary 
antibody (1:1000) or anti-PadA primary antibody (1:200), respectively, and 
secondary HRP-conjugated antibody.  
Having confirmed their relevant phenotypes, the range of S. gordonii padA and hsa 
knockout and complemented mutants, together with ΔsrtA and L. lactis negative 
controls, were investigated for ability to bind purified FH. Briefly, bacterial cells were 
incubated in purified FH solution for 1 h at 37 °C, before being washed and the 




















free eluates were then concentrated ten-fold by centrifugation under vacuum and 
the presence of FH detected by immunodot blot analysis (Figure 3.12). Purified FH 
was used as a positive control and showed good reactivity. The S. gordonii ΔpadA 
knockout mutants UB2864 and UB2723 were reduced by 90% and 50% respectively 
compared with S. gordonii WT. S. gordonii Δhsa and ΔsrtA knockout mutants were 
both reduced by approximately 80% compared with S. gordonii WT. L. lactis did not 
bind FH from solution. Complementation of the ΔpadA mutant did not restore 
binding. Complementation of the Δhsa mutant restored binding to a level greater 









Figure 3.12 Detection of bacterial binding to purified FH by immunodot blot 
analysis. Bacterial cells were incubated in FH solution. Bound proteins were 
released using glycine-HCl (method 2.7) and concentrated by centrifugation under 
vacuum. Concentrated solution was spotted onto nitrocellulose and the presence 
of FH was detected by immunodot blot analysis. Densitometry analysis was 
performed using Image Quant TL software. 
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The glycine-HCl method of eluting bound proteins was then employed to 
investigate bacterial recruitment of FH from human serum (Figure 3.13). S. gordonii 
Δhsa was 80% reduced in binding to FH compared to WT S. gordonii, and 
complementation restored binding levels to 76% of those of the WT. Likewise, both 
padA knockout strains were reduced in binding (by 96% and 75%), and 
complementation restored binding to 66% of WT levels. Binding by ΔsrtA was 
reduced to 19% of that seen for WT. No binding to FH by L. lactis was detected. 
Purified FH and human serum were used as the positive controls and showed good 
reactivity. Taken together, these data provide further evidence that S. gordonii DL1 
can bind FH from serum, particularly via Hsa, and with PadA and possibly other 
LPxTG-family proteins implicated in this process.  
 
Figure 3.13 Detection of bacterial recruitment of FH from human serum by 
immunodot blot analysis.Bacterial cells were incubated in human serum. Bound 
proteins were released using glycine-HCl (method 2.7) and concentrated by 
centrifugation under vacuum. Concentrated solution was spotted onto 
nitrocellulose and the presence of FH was detected by immunodot blot analysis. 




3.2.1.1. Potential effects of FH engagement on S. gordonii survival in 
blood 
Since FH is a negative regulator of the amplification loop in the complement 
cascade, it was hypothesised that the apparent PadA- and/or Hsa-mediated binding 
of S. gordonii to FH may limit deposition of C3b on the bacterial cell surface. This 
could, in turn, limit S. gordonii opsonisation and recognition by immune system 
effectors when in the blood stream. To test this hypothesis, S. gordonii WT and 
PadA/Hsa isogenic mutants were investigated for survival in human blood at 2 h. To 
more robustly assess the potential role of PadA in this process, consideration was 
first given to the fact that the padA gene is part of an operon comprising padC, 
padA and padB, and so knockout mutants of each of these genes were investigated. 
The functions of proteins PadC and PadB have not been elucidated to date, but the 
padB gene is predicted to encode a LPxTG-family protein containing G5 domain 
repeats. For other bacterial proteins, such domains have been associated with 
promoting binding in the formation of biofilms (Bateman, Holden and Yeats, 2005). 
The padC gene is predicted to encode a thioredoxin signature-like protein, 
potentially with a role in cytochrome aa3 maturation (Loferer, Bott and Hennecke, 
1993). At 2 h, S. gordonii ΔpadA cells showed a trend of lower survival compared to 
S. gordonii WT. The padB and padC knockout strains showed more variability, but 
the padC mutant was lower than WT in 2 out of the 3 experiments (Figure 3.14). 
Due to donor-to-donor variation, these differences were not statistically significant, 













Figure 3.14 Percentage survival of S. gordonii WT and padCAB mutants incubated 
in human whole blood for 2 h. Method 2.3. Each coloured line connecting data 
points indicates data from individual donors. P=NS as determined by Friedman 
test; n=3 (S. gordonii ∆padB, n=2, as bacteria failed to grow for one experiment) 
 
Survival of S. gordonii Δhsa was lower than S. gordonii WT on all occasions, while 
the ΔsrtA knockout mutant was lower than S. gordonii WT for 2 out of the 3 
experiments (Figure 3.15). For these studies, an additional knockout mutant of gene 
sndA was also included. SndA (streptococcal nuclease domain A) is a cell wall-
anchored LPxTG-family protein of S. gordonii with exonuclease activity (Lawler, 
2019), and a homologue of this protein had been shown to promote survival of S. 
sanguinis in blood by degrading neutrophil extracellular traps (NETs) (Morita et al., 
2014). Survival of S. gordonii ΔsndA was reduced in comparison to S. gordonii WT 














































differences were not statistically significant, but S. gordonii Δhsa exhibited reduced 
survival relative to WT for each independent experiment.  
Taken together, these data support the hypothesis that PadA, Hsa and possibly 
















Figure 3.15 Percentage survival of S. gordonii WT and adhesin mutants incubated 
in human whole blood for 2 h. Method 2.3. Each coloured line connecting data 
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3.2.2. Interactions with Vn 
Vn is a multifunctional protein present in plasma, ECM and in platelet α-granules. 
Several microorganisms have been noted for their ability to bind Vn and the 
capacity to exploit this binding to promote survival in blood (Singh, Su and Riesbeck, 
2010). Previous work had demonstrated the capacity for S. gordonii to bind Vn via a 
mechanism that involved PadA and Hsa (Haworth et al., 2017a). Since it was 
possible that this mechanism could enable S. gordonii to resist complement-
mediated lysis within the blood stream, studies were undertaken to test this 
hypothesis and to further define the specific molecular interactions of S. gordonii 
with Vn.  
Initially, experiments were performed to identify the region(s) of Vn that was 
targeted by S. gordonii. Bacterial adhesion to Vn in the presence of blocking agents 
against the N- or C-terminal domains of Vn (Figure 3.16A) was determined. A 
monoclonal antibody raised against the N-terminal region of the Vn molecule 
significantly impaired binding by S. gordonii WT by 26%, as determined by crystal 
violet assay (Figure 3.16B). The ability of bacteria to bind the C-terminal heparin-
binding domain of Vn was investigated by ELISA. ELISA was used due to concerns 
that access to the C-terminal domain of Vn would be impaired by immobilisation. 
Attachment of Vn to immobilised S. gordonii was significantly reduced by nearly 
50% in the presence of heparin relative to control in the absence of heparin (Figure 
3.16C). These data imply that S. gordonii has capacity to bind both the N-terminal 













Figure 3.16 Binding of S. gordonii to Vn domains 
(A) Schematic of Vn domains (adapted from Sa E Cunha et al., 2010), indicating 
somatomedin B domain (SMB), connecting region (CR), haemopexin domains 1 
and 2 (H1, H2), and low affinity heparin binding domains 1 and 2 (HB1, HB2).  
(B) Adherence of S. gordonii to the N-terminus of multimeric Vn. Multimeric Vn 
(+/-preincubation with mAb 8E6) was immobilised and adherence of S. gordonii 
WT cells detected by crystal violet assay. *P<0.05 relative to no mAb control; n=4.  
(C) Adherence of S. gordonii WT to the C-terminus of multimeric Vn. S. gordonii 
cells were immobilised in microtitre plate wells and incubated with multimeric Vn 
(+/- preincubation with heparin). Bound Vn was then detected by ELISA assay. 






Having demonstrated that S. gordonii bound Vn at both N- and C-terminal sites, 
investigations were then performed to explore if binding Vn via PadA and/or Hsa 
could promote S. gordonii survival. This was achieved by testing the effects of 
serum supplementation with Vn on survival of WT S. gordonii compared to ΔpadA 
or Δhsa mutants (Figure 3.17). Unlike the effects seen in whole human blood, there 
was no clear difference of S. gordonii Δhsa compared to WT after 2 h in human 
serum, regardless of the presence of Vn supplementation or not. Survival of ΔpadA 
was lower than WT on 2 occasions and comparable or slightly higher than WT on 2 
occasions and this was largely unchanged by Vn supplementation.  
Together, these data imply that the capacity for S. gordonii to bind Vn may promote 
















Figure 3.17 Effects of serum supplementation with Vn on percentage survival of S. 
gordonii WT and mutants. Washed bacterial cells were incubated in human serum 
A) without or B) with supplementation with Vn (1 µg/ml) for 2 h in a candle jar at 
37 ℃, 80 rpm. Method 2.3. Each coloured line connecting data points indicates 
data from individual donors. P=NS (not significant) as determined by Friedman 
test; n=4. 
B) Serum supplemented with 
vitronectin 
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4.1. Survival of oral Streptococcus bacteria in human blood 
Bacteraemia is a necessary precursor to platelet interaction and heart valve 
colonisation in IE pathogenesis. The periodontal and gingival tissues are extremely 
thin, highly vascular and can be disturbed easily, allowing ingress of bacteria from 
nearby biofilms (Parahitiyawa et al., 2009). For the bacteria to survive in the 
bloodstream for any length of time, they need to employ mechanisms to avoid 
detection by both cellular and humoral components of the host immune system. 
The most recent clinical evidence available suggests that post-procedure 
bacteraemia is dampened down by the host within 12 minutes following a dental 
procedure (Roberts et al., 2006). In the present in vitro study, more WT S. gordonii 
DL1 bacterial cells survived at 2 h in anti-coagulated whole blood, compared to WT 
L. lactis MG1363 cells. L. lactis is widely employed as a negative control in studies of 
Gram-positive bacteria, due to its lack of natural colonisation of human tissues. The 
difference in percentage survival between Streptococcus and the negative 
Lactococcus control bacteria supports the hypothesis that S. gordonii has evolved 
specific mechanisms to prolong survival in human blood. Even after 6 h, a 
proportion of the S. gordonii inoculum survived. Historically, the average circulation 
time in resting adults was calculated as 13 secs (Tarr, Oppenheimer and Sager, 
1933), with the circulation time being defined as the time taken for blood to travel 
from the arm vein, through the heart and lungs, up to the mouth. Based on the 
data presented here, this suggests that during bacteraemia, viable S. gordonii cells 
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will have circulated past potentially susceptible heart valve locations numerous 
times over just a few hours.  
S. gordonii was compared with other streptococcal endocarditis pathogens for 
ability to persist in human blood. As might be expected when blood samples from a 
range of donors were compared, there was significant biological variability. 
Nonetheless, of the VGS strains tested, S. oralis and S. sanguinis strains were 
comparable to S. gordonii in blood persistence. S. oralis CR834 has been shown to 
interact directly with platelets, leading to platelet microaggregate formation, 
perhaps providing a mechanism for stable septic vegetations on heart valves (Tilley 
et al., 2013). The derivation of the species name S. sanguinis (Latin for blood) 
indicates its role in the pathogenesis of IE. Platelet glycoprotein GPIb binds S. 
sanguinis directly (Kerrigan et al., 2002), suggesting a role for platelet aggregation 
in thrombus formation. A S. sanguinis cell wall-anchored exonuclease, homologous 
to SndA in S. gordonii, also contributes to survival in blood against NET bactericidal 
activity (Morita et al., 2014). Survival of the fourth VGS tested, S. mitis, was lower 
than that of S. gordonii at 2 h. S. mitis is the predominant species isolated from the 
buccal mucosa in healthy patients (Huttenhower, 2012), but in neutropenic 
patients, S. mitis is more likely than other VGS to enter the bloodstream and cause 
serious infections (Shelburne et al., 2014). S. mitis was also found to have the 
highest rate of antibiotic resistance when compared with 3 other VGS (Doern et al., 
1996). The final Streptococcus species tested, S. salivarius, is rarely implicated in IE, 
being identified as the causative agent of only 2% of VGS-associated IE (Felix and 
Gurunathan, 2014). S. salivarius is also rarely isolated from blood cultures and when 




presented here, S. salivarius exhibited the lowest level of survival in blood across 
the streptococci tested. Taken together, these data show a general correlation 
between known association with IE and VGS capacity to survive in human blood, 
with the exception of S. mitis. However, the latter discrepancy could be related to 
strain-specific variation, which was seen for other Streptococcus species tested 
here. Furthermore, as the IE disease process is multifactorial, other factors 
including abundance in the oral cavity, ability to bind platelets and other 
mechanisms for evading host immune responses, will impact overall virulence 
potential. Nonetheless, it seems logical that persistence in the bloodstream would 
enhance the opportunity for Streptococcus bacteria to colonise the endocardial 
surface and drive unwanted thrombosis, and therefore IE disease risk. These data 
also validated the use of S. gordonii as the model Streptococcus species for further 
investigating the mechanistic basis for survival in human blood. 
4.2. Interaction with complement cascade mediators 
A study published during the current project investigated complement opsonisation 
levels of four VGS: S. sanguinis, S. gordonii, S. mitis and S. oralis (Alves et al., 2019). 
S. sanguinis was found to have reduced susceptibility to complement opsonisation, 
with C3b deposition levels reduced compared to the other species investigated. 
Complement interaction was also found to be strain-specific, with strains isolated 
from systemic infections more resistant to complement opsonisation compared to 
oral isolates of the same species (Alves et al., 2019). There was diversity in C3b/iC3b 
deposition observed for S. mitis and S. oralis. It was postulated that CRP binding by 
phosphorylcholine-containing cell wall components may be critical, with cps genes 
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in S. mitis and S. oralis responsible for capsule synthesis. Serine-rich repeat 
adhesins Hsa/GspB (S. gordonii) and SrpA (S. sanguinis) were hypothesised to have 
roles in complement deposition. It was suggested that these adhesins could cause 
bacterial coating with sialic-acid soluble serum components (e.g. fetuin proteins), 
which would in turn recruit FH (Alves et al., 2019). This was supported by 
preliminary data from the Oral Microbiology group at Bristol that demonstrated the 
capacity for S. gordonii to bind serum components FH and Vn via adhesins PadA and 
Hsa, functions that may promote bacterial complement evasion. These potential 
immune evasion mechanisms were therefore investigated further in this project. 
4.2.1. Factor H 
The current investigation utilised a native form of PadA that had been expressed 
and secreted by S. gordonii, rather than with recombinant forms from E. coli used in 
previous studies. This provided greater confidence that PadA would adopt its 
regular conformation and carry any post-translational modifications such as 
glycosylation. The histidine tag also allowed immobilisation of PadA via its C-
terminus, mimicking the orientation of this adhesin when expressed on the 
bacterial cell surface. In this way, direct binding between purified FH and PadAHis6 
immobilised on Ni2+-microtitre plate wells was demonstrated, possibly implicating 
FH-binding sites in the unattached N-terminus of PadA. Similar FH binding was also 
shown using HsaHis6, indicating that both adhesins have the capacity to bind directly 
to FH. These functions were then further verified using S. gordonii bacterial cells. 
The data imply that both PadA and Hsa have the capacity to bind FH directly, but it 




Binding to FH was significantly diminished for the srtA knockout mutant, supporting 
the role of LPxTG-family adhesins in this process. Nonetheless, binding to FH was 
not ablated. The residual binding could be due to adhesins that are transiently held 
within the bacterial cell wall, as has been reported previously (Nobbs et al., 2008; 
Turner et al., 2009). Alternatively, other non-LPxTG family surface determinants of 
S. gordonii may be able to mediate binding to FH at a low level. Levels of binding for 
the hsa and srtA knockout mutants were comparable.  
Microbes can protect themselves from complement-mediated killing by recruiting 
host FH. In conjunction with factor I, FH mediates degradation of C3b, a key driver 
of the complement cascade. A range of microbes have been found to bind FH at a 
common site, located on one side of domain 20 of FH (Meri et al., 2013). Binding 
here is thought to generate a tripartite complex comprising microbial 
protein:FH:C3b, the formation of which increases FH-mediated inactivation of C3b. 
Consequently, as seen for Sbi of S. aureus (Haupt et al., 2008) or PspC of S. 
pneumoniae (Janulczyk et al., 2000), it is possible that PadA/Hsa-mediated binding 
to FH may limit deposition of C3b on the surface of S. gordonii and so promote its 
survival within the bloodstream. This hypothesis is supported by the reduced 
survival of S. gordonii padA and hsa knockout mutants at 2 h in human blood 
compared to S. gordonii WT (Figures 3.14, 3.15). 
Hsa is a sialic acid binding adhesin and as such, might be expected to mediate 
interactions with sialylated surfaces in the bloodstream. FH has specific sialic acid 
binding domains (SCRs 16-20) (Ram et al., 1998). Therefore it is possible that Hsa 
interacts with FH via sialylated serum proteins, such as fetuin, as postulated by 
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Alves et al., 2019. This may provide an explanation as to why Hsa may have a 
dominant role in human blood over PadA. Both PadA and Hsa can bind FH directly, 
but bridging with serum proteins may predominate in blood. The relative strength 
of such a binding interaction over other available sialylated proteins in the blood is 
an important consideration for future studies. Both SrpA, the serine-rich repeat 
adhesin homologue in S. sanguinis, and Hsa selectively target intact bacteria to 
sialylated ligands on platelets within human whole blood over the excess of 
alternative sialoglycan ligands in soluble and cellular components of human blood 
(Deng et al., 2014). Less is known regarding potential FH binding targets for PadA. 
However, further information was determined regarding the potential role of the 
padCAB operon. There was no evidence that LPxTG-family protein PadB is involved 
in promoting S. gordonii survival in blood, but decreased survival was seen for 2 out 
of the 3 experiments for the ∆padC mutant. PadC is a thioesterase, and thiol 
oxidoreductases have been shown in other Gram-positive bacteria to stabilise 
adhesin structures (Reardon-Robinson et al., 2015a; Reardon-Robinson et al., 
2015b). It is therefore possible that PadC may be required to ensure that PadA 
adopts the correct conformation. 
Other S. gordonii mutants were also investigated in the current study for survival in 
blood, namely srtA and sndA. The srtA knockout mutant was reduced on 2 out of 3 
occasions in survival in comparison to WT. While a more significant impairment 
might have been predicted, again this could reflect the activity of transiently 
expressed LPxTG-family proteins or other non-LPxTG family surface determinants. A 
reduction in survival was seen for the ∆sndA mutant also on 2 out of 3 occasions. As 




exonuclease SndA to promote S. gordonii survival by facilitating escape from NET-
mediated killing. This proposed mechanism of neutrophil evasion warrants further 
investigation. 
4.2.2. Vitronectin 
As well as its effects on fibrinolysis, coagulation and plasminogen activation 
following tissue injury, Vn regulates the lytic pathway in the complement system. 
Vn can inhibit C9 polymerisation and bind C5b-7, preventing this complex (C5b-7 
complex or membrane attack complex [MAC]) from inserting into bacterial cell 
membranes (Milis et al., 1993). Several microorganisms have therefore been shown 
to bind Vn and thereby block complement components, conferring serum 
resistance (Singh, Su and Riesbeck, 2010). Heparin-binding region 3 within the C-
terminus of Vn is postulated to be a common bacterial binding site (Singh, Su and 
Riesbeck, 2010). N. meningitidis has been shown to bind sulphated tyrosine 
residues in the N-terminal domain (Sa E Cunha, Griffiths and Virji, 2010), while 
inhibition of C9 binding and pore formation occurs at the heparin-binding region 
(Milis et al., 1993). Since S. gordonii-Vn binding capabilities, mediated by PadA and 
Hsa, had recently been demonstrated both with S. gordonii knockout mutants and 
purified protein (Haworth et al., 2017a; Lohiya, 2018), experiments were performed 
to determine the S. gordonii binding site on Vn. Inhibition of bacterial binding to Vn 
by addition of mAb 8E6, which binds an epitope in the N-terminus (sulphated 
tyrosine residues at positions 56 and 59), suggests that S. gordonii can directly 
interact with this N-terminus region, similar to N. meningitidis (Griffiths et al., 
2009). There was also evidence that S. gordonii binds a C-terminal heparin-binding 
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site in Vn, in common with many other microorganisms (Singh, Su and Riesbeck, 
2010), since the presence of heparin impaired attachment of S. gordonii to Vn by 
50%. It therefore seems that S. gordonii may be capable of mediating interactions 
with more than one domain of Vn, reflecting the complex multifunctional nature of 
this plasma protein. Further work is required to define if this reflects the targeting 
of different domains of Vn by PadA and Hsa. 
Through binding Vn, it is possible that S. gordonii is able to protect itself against 
complement-mediated killing in blood, or by evading immune recognition by 
coating itself in host molecules. However, S. gordonii WT serum resistance was not 
increased by the addition of Vn to serum in this study. One explanation for this 
finding could be that sufficient Vn was already present in the non-supplemented 
human serum to mediate interactions with the bacteria. S. gordonii ∆hsa showed 
no clear difference in survival compared to the WT in non-supplemented human 
serum. This result was in stark contrast to the whole blood survival assays, where 
∆hsa was nearly ablated. Serum lacks any platelets or cells compared to the whole 
blood. This suggests that Hsa may mediate the bulk of its protective effects by 
interaction with cellular components in the bloodstream. S. gordonii ∆padA, in 
contrast, was reduced compared to WT on 2 out of 4 occasions and comparable or 
slightly increased compared to WT on 2 out of 4 occasions. Vn supplementation had 
no clear effect on survival. These data imply that PadA plays a protective role in 
blood survival. Further elucidation of the relative roles of PadA and Hsa in serum 
resistance may require use of double mutants, with complementation of each 




In addition to complement inhibition, Vn binding by S. gordonii may facilitate 
attachment to damaged endothelial tissue, which is abundant with Vn (Haworth, 
2015). Host cell integrin interaction with the N-terminus of Vn would allow the C-
terminus to bind bacteria and this cross-linking may be a crucial part of 
endothelium colonisation in IE. Association of S. gordonii cells with human coronary 
artery endothelial cells is increased in the presence of serum, suggesting that a 
serum protein is implicated in endothelial-bacterial cell bridging (unpublished data). 
The presence of Vn at exposed ECM sites in the oral cavity is also likely to play a 
role in bacterial attachment and biofilm formation. Interestingly, significant 
increases in Vn (as well as fibronectin and laminin) were found in the periodontal 
ligament of teeth that had undergone orthodontic tooth movement in a human in 
vivo study (Morales-González et al., 2010). As periodontal and gingival tissues are 
disrupted during separator placement and other orthodontic procedures, the 
increased expression of these ECM proteins may be a critical mechanism for 
streptococcal ingress into the bloodstream. 
4.3. Hsa-like and PadA-like proteins 
PadA and Hsa interact with human platelets and are implicated in biofilm formation 
within the human body. As such, these two adhesins are likely to be major virulence 
factors in the pathogenesis of S. gordonii IE. In further support of this, data 
presented in this project indicate that PadA and Hsa both bind FH and Vn, which 
may promote survival in blood. Unpublished data suggest that C4BP may also 
interact with PadA and Hsa (Lohiya, 2018). C4BP is another regulatory protein that 
modulates the classical and lectin pathways of the complement system, and can act 
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as a bridging molecule to facilitate S. pyogenes adhesion to and invasion of 
endothelial cells (Ermert et al., 2013). Given their critical role in IE pathogenesis, the 
distribution of PadA- and Hsa-like adhesins across other potential IE pathogens is 
therefore of interest. 
PadA homologues are found in a range of streptococci and in Abiotrophia defectiva 
(Table 4.1). Streptococcus cristatus has a protein with 99.79% identity to PadA. This 
microorganism is another VGS member. Descriptions of S. cristatus-associated 
endocarditis are rare, but this may well reflect difficulties in phenotypic 
identification of this species. A PadA-like protein, FmtB, is also found in S. oralis 
NCTC 11427. This strain was used in this project (UB2178) and found to exhibit high 
survival levels in human blood relative to S. gordonii. Indeed, the fact that PadA-like 
proteins have been identified in most of the species investigated in this project, but 
not S. salivarius, suggests that PadA may be conserved amongst a number of 





Table 4.1 A selection of bacterial proteins with high homology to S. gordonii DL1 
PadA retrieved from BLASTP online database 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed 24/10/19) 
Species Protein Percentage identity (%)* 
















S. sanguinis Cell wall surface protein 69.94 




S. oralis subsp. tigurinus Cell surface protein 62.94 








S. oralis ATCC 35037 / 
NCTC 11427 
FmtB protein 58.05 








Abiotrophia defectiva Hypothetical protein 41.84 
*Percentage identity describes the percentage of amino acid residues with a direct 
match in alignment to the entire S. gordonii PadA amino acid sequence. 
 
Hsa homologues are presented in Table 4.2. GspB of S. gordonii M99 is a 
homologue of Hsa. GspB orthologues have previously been found to be prevalent, 
but not ubiquitous, amongst oral streptococcal strains (Takamatsu et al., 2005). All 
of the streptococcal species investigated in this project, which have also been 
102 
associated with bacteraemia following separator placement, have proteins with 
homology to the Hsa protein of S. gordonii DL1. S. pneumoniae is a highly invasive 
pathogen implicated in pneumonia, septicaemia and meningitis and also displays a 
Hsa homologue. Aerococcus viridans, another microorganism with an Hsa 
homologue, is a causative agent of IE (Pien et al., 1984). 
Table 4.2 A selection of bacterial proteins with high homology to S. gordonii DL1 
Hsa, retrieved from BLASTP online database 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed 24/10/19) 
Species Protein Percentage identity (%)* 
S. gordonii M99 GspB 96.35 








S. mitis Serine-rich repeat 
glycoprotein 
55.56 












Aerococcus viridans LPXTG cell wall domain-
containing protein 
31.00 
*Percentage identity describes the percentage of amino acid residues with a direct 
match in alignment to the entire S. gordonii Hsa amino acid sequence. 
 
Taken together, the presence of both PadA and Hsa homologues across a range of 
streptococcal and other bacterial species that are implicated in IE supports the 




disease, and therefore could represent suitable therapeutic targets for the 
prevention of IE. 
4.4. Mechanisms for S. gordonii survival in blood  
The known and proposed interactions of S. gordonii with the human complement 
system are summarised in Figure 4.1. S. gordonii binds Vn and FH, negative 
regulators of C5b-9 and C3b deposition, respectively. PadA and Hsa may also bind 
C4b, thereby inhibiting the classical and lectin pathways. As well as avoiding 
complement detection, evasion of macrophages by S. gordonii is possible through 
resistance to ROS and delaying the maturation of phagosomes (Croft et al., 2018). 
Data in this project (Figures 3.15, 3.17) support the idea that Hsa may confer its 
protective effects in the bloodstream by preferentially interacting with cellular 
components. Such resistance of bacteria to cellular killing by the host is also likely 
to be an important virulence determinant of IE (Young Lee et al., 2006). Bacterial 
aggregation and activation of platelets under flow conditions in the bloodstream 
means that platelets are also implicated in promoting bacterial survival in blood and 
the progression of IE, with the platelets acting as “Trojan Horse” carriers of bacteria 



















Figure 4.1 Summary of interactions between S. gordonii and the complement system. Negative regulators of the complement system are 





4.5. Revised model for streptococcal IE pathogenesis 
Despite significant shifts in the epidemiology of IE in recent years, with an observed 
increase in staphylococcal endocarditis in new risk groups, it is still important to 
understand streptococcal IE pathogenesis. IE is increasing in the UK, in keeping with 
global trends. In a recent study of a rural UK population, streptococci were the 
predominant cause of healthcare-associated IE, in contrast to other areas of the 
world where staphylococci are the main cause (Hughes, Epstein and Prasad, 2019). 
A revised model for streptococcal IE pathogenesis in the context of orthodontic 
procedures is depicted in Figure 4.2. In summary, S. gordonii colonises dental hard 
surfaces and exposed ECM surfaces in the oral cavity. Upregulation of Vn 
expression during orthodontic tooth movement may aid S. gordonii colonisation. 
Orthodontic procedures, such as separator placement, induce bacteraemia, with 
the bacterial cells in the bloodstream recruiting both Vn and FH, evading 
complement-mediated killing. Direct binding of bacterial cells to platelets causes 
infected microthrombi to form. Bacterial survival in the bloodstream then allows 
streptococcal colonisation of damaged endocardial surfaces via putative Vn and FH 


























Figure 4.2 Model for the pathogenesis of orthodontics-associated streptococcal IE 








4.6. Clinical implications  
The clinical diagnosis of IE is complex. The standardised Duke-Li criteria (Li et al., 
2000a), based upon the use of both imaging and microbiology, form the basis of IE 
diagnosis, but there are limitations to this classification (Iung and Duval, 2019). 
Molecular microbiological techniques are therefore likely to form the basis of future 
diagnostic techniques, due to their sensitivity and specificity (Faraji et al., 2018). For 
this, the ability to differentiate between streptococcal endocarditis pathogens is 
important, because clinical outcomes and disease progression are likely to differ 
between species and strains. In the current project, not only did the time course of 
survival of different streptococci vary, but so did the resistance to complement 
deposition between bacteraemia-associated strains compared to oral isolates (Alves et 
al., 2019). This project therefore highlights the need for a better understanding of 
virulence across the oral streptococci. 
The mechano-transduction that occurs during orthodontic tooth movement enables 
remodelling of periodontal ligament tissues, allowing the desired tooth movement to 
occur. This conversion of biomechanical stimuli into intracellular biochemical stimuli is 
complex. ECM changes as a result of tooth movement result in integrin clustering and 
activation and signal transduction into cells, stimulating intracellular signalling 
pathways (Feller et al., 2015). Based on former studies and the data presented here, 
significant increases in expression of ECM components, such as fibronectin and Vn, 
during orthodontic tooth movement (Morales-González et al., 2010) may be predicted 
to facilitate colonisation of damaged gingival tissues by oral streptococci that bind 
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these ECM components. The orthodontic patient may therefore be inherently more at 
risk of developing bacteraemia from oral bacteria such as S. gordonii and thus 
potentially at greater risk of IE. 
The orthodontic profession is in a unique position, having regular access to patients at 
ages when they are most likely to be developing IE as a child. The orthodontic team 
must be aware of the causes, signs and symptoms of IE and promote preventive advice 
where possible. Despite being rare, the consequences of developing IE are devastating. 
It may be necessary to re-visit clinical guidelines for the prevention of IE in the future.  
Mechanisms for streptococcal survival in the bloodstream, such as those identified in 
this project, could be targeted for the prevention or treatment of IE in the future. 
Novel inhibitors, perhaps applied topically at the site of separator placement, for 
example, could be targeted against known bacterial-host binding interactions to 
prevent bacteria using the immune system to their advantage. This would promote 
host clearance of bacteria from the blood stream and thus reduce IE disease risk. This 
approach could also negate the need for antibiotic usage, which would be beneficial in 









Key findings are: 
1) A range of streptococcal species are linked to bacteraemia following 
orthodontic separator placement. 
2) Blood survival rates are species- and strain-dependent, but there is a general 
correlation between association of species with IE and persistence in blood. 
3) S. gordonii PadA and Hsa bind FH of the complement system. It is postulated 
that interaction primarily by Hsa enables bacterial cell evasion of the host 
immune system.  
4) S. gordonii binds Vn at both N-terminal and C-terminal sites via PadA and Hsa. 
This represents a second mechanism via which S. gordonii may evade the host 
immune system, primarily by PadA. 
5) Hsa-mediated bacterial survival in blood may be more related to cellular 
interactions than PadA-mediated survival. 
6) Hsa-like and PadA-like proteins are found in a range of Streptococcus and other 
bacterial species associated with IE and therefore represent potential targets 
for the prevention or management of IE. 
7) The orthodontic profession should be vigilant regarding the risks of 
bacteraemia associated with orthodontic procedures, especially considering the 
changes in ECM composition during active tooth movement that could promote 
bacteraemia with VGS. 
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4.8. Future work 
i) Determination of the relative importance of Hsa and PadA in serum 
resistance 
The use of double hsa and padA knockout mutants, with complementation of each 
protein in turn, would be invaluable for determining the relative importance of these 
proteins in serum resistance and potential binding to C3b.  
ii) Evidence of PadA/Hsa complex formation 
Both Hsa and PadA cell-surface proteins have been implicated in colonisation, biofilm 
formation, platelet binding and serum resistance. Co-localisation studies with 
fluorescent probes would enable detection of Hsa/PadA complexes on bacterial cell 
surfaces.  
iii) Investigation of FH as a bridging molecule for host interactions 
FH is thought to mediate host cell-microbe interactions, with FH acting as a bridging 
molecule (Jozsi, 2017). Bacterial adhesion of human cardiac endothelial cells could be 
investigated in the presence of serum depleted in or supplemented with FH. 
iv) Determination of the molecular mechanism for Vn binding by Hsa and PadA 
Further work is required to identify domains of Vn targeted by Hsa and PadA. This 
could be achieved by examining the effects of blocking agents on padA and hsa 






v) Further evidence of S. gordonii neutrophil evasion 
SndA contribution to survival in blood via evasion of NET-mediated killing needs further 
investigation. 
vi) Clinical perspectives 
The effect of upregulated ECM protein expression in the PDL during orthodontic tooth 
movement on bacterial colonisation and entry into the bloodstream should be 
investigated further. New diagnostic procedures or clinical monitoring techniques 
could be developed based on Hsa/PadA antibodies. Ultimately, better understanding 
regarding the evasion of host defences by streptococci in the bloodstream could lead 
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